data_2ap7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ap7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.7 t . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.59 67.47 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.288 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -46.72 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.4 -17.98 62.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.586 0.707 . . . . 0.0 109.941 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.58 -28.34 61.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.817 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.11 -26.48 28.53 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -74.92 -33.1 55.93 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.822 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -77.46 -25.86 50.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.396 0.617 . . . . 0.0 109.588 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 35.7 mt -77.3 -22.28 52.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.282 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.18 -50.06 75.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.706 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.58 -11.71 33.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.213 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.706 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.8 tp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.732 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.31 -28.35 69.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.115 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 t -81.11 -44.98 17.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.96 -16.62 63.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.54 0.686 . . . . 0.0 109.708 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 7.2 mt -67.57 -28.56 67.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.86 -26.3 32.26 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -73.94 -40.7 43.19 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.676 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.4 mt -77.21 -15.85 59.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.33 0.586 . . . . 0.0 110.201 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -77.51 -24.05 50.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.062 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -55.24 -53.54 54.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.484 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.674 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -94.61 -24.65 17.11 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.734 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 6.9 tp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.223 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 47.7 t . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.91 -28.96 71.13 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.302 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -44.41 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 -8.31 55.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.874 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -73.45 -29.03 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.126 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -85.76 -29.83 25.42 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.433 ' O ' ' HE2' ' A' ' 18' ' ' LYS . . . -76.51 -32.48 50.94 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.302 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.485 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.3 tt -77.18 -19.69 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.271 0.557 . . . . 0.0 110.34 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 26.0 mt -75.47 -22.14 57.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.65 -48.55 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.502 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.694 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.57 -12.31 34.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 111.06 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.694 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.618 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.96 0.41 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.62 -29.69 75.88 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.27 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -77.24 -46.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.56 -18.31 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.046 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt -68.14 -31.85 71.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.804 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.4 -28.15 23.12 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.59 -34.12 45.35 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.439 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.514 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.16 -23.68 51.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.208 0.528 . . . . 0.0 110.052 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.16 -23.19 51.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.626 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.74 -50.82 69.55 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.449 -178.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.695 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.33 -9.64 41.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.319 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.695 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.717 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.31 -27.66 69.65 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.15 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -45.63 20.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.67 -15.25 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 109.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 7.2 mt -69.5 -27.99 65.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.15 -30.61 16.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.48 -0.866 . . . . 0.0 110.959 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 18' ' ' LYS . . . -76.5 -32.38 51.29 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.234 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.441 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -80.06 -18.84 48.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.336 179.116 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -76.9 -23.75 52.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.015 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CE ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.91 -46.75 89.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.011 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.722 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.45 -14.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 111.04 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.722 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.2 tt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.88 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.904 0.383 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.68 -25.86 64.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.168 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -44.41 21.25 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.05 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 109.783 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.12 -28.4 66.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.766 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.35 -21.89 57.71 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.23 74.72 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.011 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.6 mp -77.14 -24.5 51.6 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.5 0.667 . . . . 0.0 109.623 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 11.6 tp -76.75 -22.58 53.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.707 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.629 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.66 -49.02 79.18 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.447 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.689 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.98 -11.39 36.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.0 0.428 . . . . 0.0 111.209 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.689 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.674 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.55 -29.19 71.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.361 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -81.79 -45.79 15.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.095 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.63 -15.14 62.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.485 0.66 . . . . 0.0 109.822 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.99 -28.48 67.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.819 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.22 -25.36 37.14 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.56 21.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.768 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.481 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 1.8 mt -77.04 -15.45 59.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.507 0.67 . . . . 0.0 109.987 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 9.0 tp -75.26 -22.39 57.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.459 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.663 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.96 -48.95 79.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.145 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.63 -11.02 35.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.709 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -60.72 -26.18 64.59 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.2 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 m -69.79 -49.32 53.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.47 63.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.732 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.442 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 5.5 mt -73.64 -28.39 61.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.831 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.86 -22.85 48.08 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.28 -40.78 54.76 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.83 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.27 -22.21 52.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 109.771 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 21.6 mt -76.36 -22.51 54.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.2 -49.67 76.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.987 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.721 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.71 -10.85 35.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.908 0.385 . . . . 0.0 111.387 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.721 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.5 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.679 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA2' ' CD2' ' A' ' 13' ' ' LEU . . . -65.33 -27.99 73.07 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.3 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -46.24 40.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.11 -9.77 58.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.41 ' CD2' ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.82 -29.55 62.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.56 -22.8 49.45 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.14 -43.55 39.2 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.79 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.33 -23.46 50.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 109.71 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 7.0 tp -76.78 -23.0 52.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.653 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.06 -49.24 78.66 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.367 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.698 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.96 -11.49 36.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.203 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.698 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.51 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.868 0.366 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.87 -25.97 66.54 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.31 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -80.87 -44.6 18.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 -8.69 56.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.117 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.64 -31.66 63.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.27 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.2 -30.7 16.07 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.53 -33.36 48.03 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.223 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.479 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -77.19 -20.39 55.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.5 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.6 mt -76.55 -22.55 54.2 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.062 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.19 -49.3 78.19 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.023 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.707 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.68 -10.91 35.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.262 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.707 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.0 tt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.669 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.2 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.19 69.58 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.178 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.7 m -75.05 -48.36 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.59 -16.92 60.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mt -74.03 -31.52 62.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.38 -29.85 18.16 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.49 -33.79 46.86 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.089 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 4.8 tt -77.33 -20.9 54.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.066 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 4.3 mt -76.73 -22.61 53.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.653 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.58 -48.43 81.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.674 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.35 -11.01 36.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.22 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 9.2 tt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.616 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -61.75 -28.45 70.04 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.11 -49.24 52.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.007 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 -16.05 61.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 9.0 mt -73.66 -33.92 64.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.29 -27.48 27.77 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.24 -31.35 55.18 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.932 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 4.1 mt -77.09 -25.64 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 109.681 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.544 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.1 mt -76.25 -22.1 55.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.791 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.629 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.89 -48.42 81.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.164 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.689 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.07 -11.57 35.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.174 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.689 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.1 tt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.282 -0.865 . . . . 0.0 111.69 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.3 t . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.781 0.324 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.19 -25.8 66.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.353 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -79.78 -45.26 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -8.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.255 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -73.95 -37.6 64.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.34 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.35 -26.34 30.85 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.26 -41.0 27.42 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.828 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.519 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -77.48 -20.05 54.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.358 0.599 . . . . 0.0 109.865 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.432 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 16.1 tp -76.86 -22.56 53.31 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.02 -50.09 73.42 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.372 -178.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.55 -11.32 34.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.711 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 7.3 tp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.754 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.46 -28.14 70.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -73.78 -49.16 26.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.5 -17.53 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.514 0.673 . . . . 0.0 110.164 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.67 -28.23 61.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.852 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.3 -24.91 38.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.7 -38.9 41.78 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.033 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.481 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 4.2 mm? -77.4 -19.79 55.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.297 0.57 . . . . 0.0 110.006 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 17' ' ' LEU . 2.1 tm? -75.77 -23.88 55.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.635 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.84 -50.27 72.93 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.68 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.673 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.34 -11.39 35.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.529 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.673 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.785 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.6 t . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.953 0.406 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.57 -26.22 66.32 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.331 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.23 -48.52 28.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.037 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.94 -16.18 61.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.481 0.658 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mt -73.52 -28.66 62.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.959 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.23 -21.88 47.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.15 -38.33 35.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.29 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.462 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 5.3 mt -77.44 -23.32 50.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.33 0.586 . . . . 0.0 110.01 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 41.1 mt -76.65 -22.4 54.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.628 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.46 -49.45 77.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.034 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.38 -10.14 39.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.358 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.711 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 4.5 tt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.653 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 13' ' ' LEU . . . -63.63 -27.0 70.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.308 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -74.41 -46.89 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.26 -9.26 58.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.144 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 ' CD2' ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.83 -32.76 63.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.275 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . -83.21 -24.93 50.22 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.86 -47.22 77.09 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.48 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 9.0 mp -76.95 -16.53 59.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.64 0.733 . . . . 0.0 109.442 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 6.6 tt -75.55 -22.76 56.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.729 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.648 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.4 -49.16 78.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.105 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.699 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.3 -10.26 39.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.38 . . . . 0.0 111.321 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.699 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.259 -0.876 . . . . 0.0 111.602 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.29 -27.76 71.2 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -81.3 -44.33 17.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.09 -16.64 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 mt -73.08 -29.03 62.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.72 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 17' ' ' LEU . . . -88.53 -26.76 26.7 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -77.05 -33.24 46.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.692 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 37.3 tp -77.91 -30.14 50.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.0 110.698 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.548 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -77.29 -22.06 52.59 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.148 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.15 -49.16 78.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -178.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.34 -11.99 33.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 111.306 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.681 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.668 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 41.8 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -58.04 -25.78 57.29 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -53.37 35.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.141 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 -24.38 58.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.556 0.693 . . . . 0.0 110.3 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.498 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 11.3 mt -73.97 -28.22 61.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.044 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.6 -21.82 61.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.96 45.02 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.113 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 20.2 mt -77.8 -19.25 55.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.405 0.621 . . . . 0.0 110.184 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 6.7 tp -76.07 -22.58 55.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.63 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.61 -48.01 83.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.673 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.08 -11.19 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.883 0.373 . . . . 0.0 111.245 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.673 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 4.1 tp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.481 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -61.66 -32.01 79.98 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -66.62 -51.47 55.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 109.899 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.78 -16.71 62.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.503 0.668 . . . . 0.0 110.149 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 8.4 mt -72.98 -28.31 62.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.97 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.3 -31.82 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.43 -36.17 45.16 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.633 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 15.6 mt -77.3 -15.11 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.509 HD11 HG22 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -74.54 -22.65 58.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.771 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.6 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.57 -47.68 80.54 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.303 -178.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.692 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.72 -13.74 28.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.279 179.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.692 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.519 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.5 t . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.94 0.4 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.33 -27.05 70.11 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.534 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -71.86 -47.84 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 -14.87 61.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.512 0.673 . . . . 0.0 110.069 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 mt -73.59 -28.83 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.989 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.61 -22.34 43.78 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.45 -41.95 50.19 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.801 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.504 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.46 -21.48 52.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.464 0.649 . . . . 0.0 109.757 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 14.2 tp -76.55 -22.59 54.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.882 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.637 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.87 -49.81 74.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.124 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.16 -10.18 39.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.389 . . . . 0.0 111.354 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.709 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 5.0 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.677 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.886 0.374 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.57 -33.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.489 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.78 99.06 0.19 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.76 -17.88 52.71 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.58 2.187 . . . . 0.0 112.573 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 18.0 t -63.47 -53.86 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.64 -27.77 65.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.264 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.41 -36.65 23.07 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 5' ' ' VAL . 2.0 pp -74.71 -44.57 49.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.06 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' N ' HD11 ' A' ' 8' ' ' LEU . 77.7 t -62.34 -38.67 81.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.956 0.408 . . . . 0.0 109.949 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.96 -26.59 67.47 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.288 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -46.72 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.4 -17.98 62.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.586 0.707 . . . . 0.0 109.941 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.58 -28.34 61.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.817 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.11 -26.48 28.53 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -74.92 -33.1 55.93 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.822 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -77.46 -25.86 50.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.396 0.617 . . . . 0.0 109.588 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.497 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 35.7 mt -77.3 -22.28 52.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.282 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.624 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.18 -50.06 75.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.706 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.58 -11.71 33.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.213 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.706 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.8 tp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.732 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.961 0.41 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.1 pt -90.57 -25.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.416 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.9 -70.53 0.37 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.633 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 18.3 Cg_exo -67.66 1.13 3.42 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.918 2.412 . . . . 0.0 113.357 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.28 -55.08 11.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.815 0.34 . . . . 0.0 111.062 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.51 -27.56 6.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.558 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.9 -30.55 47.08 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 23.6 mt -75.74 -48.13 23.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.956 0.408 . . . . 0.0 109.941 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.64 -41.92 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.352 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.31 -28.35 69.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.115 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 t -81.11 -44.98 17.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.96 -16.62 63.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.54 0.686 . . . . 0.0 109.708 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 7.2 mt -67.57 -28.56 67.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.86 -26.3 32.26 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -73.94 -40.7 43.19 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.676 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.4 mt -77.21 -15.85 59.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.33 0.586 . . . . 0.0 110.201 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -77.51 -24.05 50.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.062 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -55.24 -53.54 54.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.484 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.674 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -94.61 -24.65 17.11 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.734 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 16' ' ' LEU . 6.9 tp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.223 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.18 -20.89 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.397 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 89.11 99.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.352 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.11 7.85 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.539 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -52.93 -55.55 11.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.67 -26.99 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.75 -27.07 65.69 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.216 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.06 -48.15 18.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.899 0.381 . . . . 0.0 110.342 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 47.7 t -59.7 -39.79 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.112 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.91 -28.96 71.13 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.302 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -44.41 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 -8.31 55.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.874 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -73.45 -29.03 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.126 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.421 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -85.76 -29.83 25.42 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.433 ' O ' ' HE2' ' A' ' 18' ' ' LYS . . . -76.51 -32.48 50.94 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.302 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.485 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.3 tt -77.18 -19.69 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.271 0.557 . . . . 0.0 110.34 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 26.0 mt -75.47 -22.14 57.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.65 -48.55 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.502 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.694 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.57 -12.31 34.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 111.06 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.694 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.618 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.7 pt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.826 0.346 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.7 mt -86.28 58.63 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.084 0.469 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.32 71.22 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.27 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.28 0.6 5.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.138 2.558 . . . . 0.0 113.267 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.469 ' HA ' ' CG ' ' A' ' 8' ' ' LEU . 16.6 t -53.32 -55.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -28.5 64.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.459 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.92 -39.6 13.14 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.94 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' CG ' ' HA ' ' A' ' 5' ' ' VAL . 2.5 pp -77.14 -48.37 17.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.116 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -62.24 -34.82 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 110.033 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.62 -29.69 75.88 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.27 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -77.24 -46.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.56 -18.31 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.046 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.5 mt -68.14 -31.85 71.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.804 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.4 -28.15 23.12 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.59 -34.12 45.35 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.439 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.514 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.16 -23.68 51.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.208 0.528 . . . . 0.0 110.052 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.16 -23.19 51.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.626 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.74 -50.82 69.55 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.449 -178.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.695 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.33 -9.64 41.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.319 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.695 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.717 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.98 -33.2 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.714 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.22 85.51 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.131 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.58 -9.16 17.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.876 2.384 . . . . 0.0 113.322 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 16.2 t -56.54 -53.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 0.0 110.835 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.53 -27.44 69.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.12 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.47 -35.38 26.2 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 5' ' ' VAL . 4.1 pp -73.63 -43.96 58.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.817 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.403 ' N ' HD12 ' A' ' 8' ' ' LEU . 89.3 t -64.07 -40.22 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.31 -27.66 69.65 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.15 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -45.63 20.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.67 -15.25 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 109.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 7.2 mt -69.5 -27.99 65.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.15 -30.61 16.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.48 -0.866 . . . . 0.0 110.959 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 18' ' ' LYS . . . -76.5 -32.38 51.29 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.234 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -80.06 -18.84 48.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.336 179.116 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -76.9 -23.75 52.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.015 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CE ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.91 -46.75 89.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.011 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.722 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.45 -14.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 111.04 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.722 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.2 tt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.88 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.78 0.324 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.11 -39.92 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.5 85.76 0.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.358 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.07 -13.76 33.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.729 2.286 . . . . 0.0 112.754 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.42 -55.33 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 pp -49.33 -27.49 3.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.879 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.04 -31.51 42.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.263 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.8 mt -77.19 -48.41 17.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.882 0.372 . . . . 0.0 110.383 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.11 -41.04 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.439 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.68 -25.86 64.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.168 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -44.41 21.25 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.05 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 109.783 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.12 -28.4 66.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.766 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.35 -21.89 57.71 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.23 74.72 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.011 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.6 mp -77.14 -24.5 51.6 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.5 0.667 . . . . 0.0 109.623 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 11.6 tp -76.75 -22.58 53.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.707 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.629 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.66 -49.02 79.18 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.447 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.689 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.98 -11.39 36.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.0 0.428 . . . . 0.0 111.209 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.689 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.674 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 mp 65.29 95.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.86 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.78 -12.12 30.06 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.787 2.325 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.6 t -53.88 -55.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 mt -47.34 -27.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.044 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.36 -36.36 27.16 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.13 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.53 -46.78 21.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.4 t -54.94 -35.87 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.55 -29.19 71.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.361 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -81.79 -45.79 15.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.095 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.63 -15.14 62.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.485 0.66 . . . . 0.0 109.822 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.99 -28.48 67.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.819 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.22 -25.36 37.14 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.56 21.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.768 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.481 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 1.8 mt -77.04 -15.45 59.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.507 0.67 . . . . 0.0 109.987 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 9.0 tp -75.26 -22.39 57.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.459 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.663 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.96 -48.95 79.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.145 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.63 -11.02 35.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.709 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pt -97.78 19.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.382 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 4' ' ' PRO . . . 134.28 124.79 2.51 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.612 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.402 ' HD3' ' HA2' ' A' ' 3' ' ' GLY . 19.9 Cg_exo -67.24 -0.85 5.41 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.797 2.331 . . . . 0.0 113.291 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.5 t -53.28 -55.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.39 -28.32 69.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.461 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.66 -25.46 58.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.497 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -77.31 -43.14 34.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.531 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 43.7 t -69.26 -34.71 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -60.72 -26.18 64.59 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.2 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 m -69.79 -49.32 53.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.47 63.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.732 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.442 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 5.5 mt -73.64 -28.39 61.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.831 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.86 -22.85 48.08 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.28 -40.78 54.76 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.83 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.27 -22.21 52.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 109.771 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 21.6 mt -76.36 -22.51 54.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.657 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.2 -49.67 76.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.987 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.721 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.71 -10.85 35.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.908 0.385 . . . . 0.0 111.387 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.721 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.5 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.679 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.794 0.33 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -87.46 89.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.199 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . 173.99 -50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.772 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 38.4 Cg_exo -60.19 -14.77 30.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.627 2.218 . . . . 0.0 112.881 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.6 -55.61 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.941 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.78 -28.57 67.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.575 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.73 38.26 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.513 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -77.15 -44.23 31.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.661 0.267 . . . . 0.0 110.336 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.535 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 51.8 t -70.07 -33.86 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA2' ' CD2' ' A' ' 13' ' ' LEU . . . -65.33 -27.99 73.07 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.3 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -46.24 40.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.11 -9.77 58.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.41 ' CD2' ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.82 -29.55 62.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.56 -22.8 49.45 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.14 -43.55 39.2 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.79 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.33 -23.46 50.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 109.71 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 7.0 tp -76.78 -23.0 52.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.653 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.06 -49.24 78.66 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.367 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.698 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.96 -11.49 36.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.203 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.698 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.51 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.482 HG12 ' N ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.482 ' N ' HG12 ' A' ' 1' ' ' ILE . 2.2 mp 65.75 73.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.137 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.37 91.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.404 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 33.4 Cg_exo -59.29 -19.25 49.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.605 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -56.93 -55.3 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.26 -27.18 3.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.104 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.31 -28.09 56.44 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.63 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 11.8 mt -77.21 -48.45 17.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.927 0.394 . . . . 0.0 110.478 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.21 -41.58 84.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.226 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.87 -25.97 66.54 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.31 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -80.87 -44.6 18.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 -8.69 56.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.117 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.64 -31.66 63.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.27 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.2 -30.7 16.07 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.53 -33.36 48.03 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.223 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.479 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -77.19 -20.39 55.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.5 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.6 mt -76.55 -22.55 54.2 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.062 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.625 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.19 -49.3 78.19 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.023 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.707 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.68 -10.91 35.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.262 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.707 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.0 tt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.669 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.79 0.328 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 pt -87.41 9.03 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.386 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.28 101.32 1.54 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.374 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.39 -21.29 36.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.519 2.146 . . . . 0.0 112.622 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -66.03 -55.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.751 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mt -60.19 -28.3 67.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.632 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.71 -29.46 47.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.55 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -77.14 -42.11 39.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 110.551 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.554 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 46.2 t -67.98 -35.58 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.19 69.58 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.178 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.7 m -75.05 -48.36 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.59 -16.92 60.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 mt -74.03 -31.52 62.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.38 -29.85 18.16 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.49 -33.79 46.86 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.089 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 4.8 tt -77.33 -20.9 54.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.066 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 4.3 mt -76.73 -22.61 53.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.653 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.58 -48.43 81.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.674 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.35 -11.01 36.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.22 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.674 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 9.2 tt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.616 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.922 0.391 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 pt -100.24 84.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.222 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.37 88.79 0.54 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.537 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.96 -18.17 55.79 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.545 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.45 -55.38 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.99 -26.96 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.734 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.81 -27.17 67.5 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.1 mt -75.94 -48.19 22.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.947 0.403 . . . . 0.0 109.995 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.03 -33.66 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -61.75 -28.45 70.04 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.11 -49.24 52.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.007 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 -16.05 61.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 9.0 mt -73.66 -33.92 64.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.29 -27.48 27.77 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.24 -31.35 55.18 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.932 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.45 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 4.1 mt -77.09 -25.64 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 109.681 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.544 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 18.1 mt -76.25 -22.1 55.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.791 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.629 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.89 -48.42 81.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.164 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.689 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.07 -11.57 35.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.174 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.689 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.1 tt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.282 -0.865 . . . . 0.0 111.69 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 28.8 mt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.866 0.365 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.8 mt 68.92 -66.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.134 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.74 122.16 0.6 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.65 -13.55 26.58 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 112.77 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 17.7 t -61.64 -56.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.8 pp -57.52 -27.88 62.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.38 -35.84 25.3 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.298 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.423 ' CD2' ' HA ' ' A' ' 5' ' ' VAL . 1.2 pp -77.47 -40.75 42.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.3 t -64.46 -41.49 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.288 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.19 -25.8 66.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.353 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -79.78 -45.26 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -8.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.255 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -73.95 -37.6 64.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.34 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.35 -26.34 30.85 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.26 -41.0 27.42 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.828 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.519 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -77.48 -20.05 54.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.358 0.599 . . . . 0.0 109.865 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.432 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 16.1 tp -76.86 -22.56 53.31 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.02 -50.09 73.42 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.372 -178.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.55 -11.32 34.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.711 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 7.3 tp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.754 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.888 0.375 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 pt -97.98 34.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.03 102.07 0.01 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.03 -14.87 44.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.64 2.227 . . . . 0.0 112.683 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -54.29 -55.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -26.86 11.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.868 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.93 61.59 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.559 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 mt -75.35 -48.32 23.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.835 0.35 . . . . 0.0 110.067 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.4 t -65.33 -35.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.46 -28.14 70.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -73.78 -49.16 26.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.5 -17.53 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.514 0.673 . . . . 0.0 110.164 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.67 -28.23 61.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.852 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.3 -24.91 38.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.7 -38.9 41.78 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.033 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.481 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 4.2 mm? -77.4 -19.79 55.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.297 0.57 . . . . 0.0 110.006 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' CD1' ' O ' ' A' ' 17' ' ' LEU . 2.1 tm? -75.77 -23.88 55.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.635 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.84 -50.27 72.93 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.68 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.673 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.34 -11.39 35.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.529 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.673 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.785 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.6 pt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.62 51.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.23 -88.99 0.89 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.685 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.02 -16.07 43.19 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.618 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.475 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 28.3 t -58.66 -55.42 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 mt -58.18 -28.43 64.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.425 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.16 -40.53 11.32 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.01 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' CD2' ' HA ' ' A' ' 5' ' ' VAL . 3.8 pp -77.48 -44.32 29.26 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.245 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.6 t -58.9 -35.62 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 110.307 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.57 -26.22 66.32 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.331 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.23 -48.52 28.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.037 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.94 -16.18 61.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.481 0.658 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mt -73.52 -28.66 62.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.959 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.23 -21.88 47.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.15 -38.33 35.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.29 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.462 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 5.3 mt -77.44 -23.32 50.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.33 0.586 . . . . 0.0 110.01 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 41.1 mt -76.65 -22.4 54.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.628 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.46 -49.45 77.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.034 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.711 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.38 -10.14 39.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.358 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.711 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 4.5 tt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.653 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.818 0.342 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.421 ' CG2' ' CG2' ' A' ' 5' ' ' VAL . 12.8 mm -71.69 90.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . -76.67 -41.41 24.28 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.371 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 79.7 Cg_exo -45.37 -26.85 2.82 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.459 2.106 . . . . 0.0 113.139 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' CG2' ' CG2' ' A' ' 2' ' ' ILE . 29.5 t -59.09 -55.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.986 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pp -49.99 -26.98 4.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.021 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.78 -27.76 58.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.653 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.12 -48.51 17.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.868 0.366 . . . . 0.0 110.355 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.43 -35.18 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.412 ' HA2' ' CD2' ' A' ' 13' ' ' LEU . . . -63.63 -27.0 70.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.308 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -74.41 -46.89 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.26 -9.26 58.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.144 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 ' CD2' ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.83 -32.76 63.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.275 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.532 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . -83.21 -24.93 50.22 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.86 -47.22 77.09 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.48 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 9.0 mp -76.95 -16.53 59.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.64 0.733 . . . . 0.0 109.442 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 6.6 tt -75.55 -22.76 56.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.729 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.648 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.4 -49.16 78.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.105 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.699 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.3 -10.26 39.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.38 . . . . 0.0 111.321 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.699 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.259 -0.876 . . . . 0.0 111.602 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 2' ' ' ILE . 10.4 tp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.793 0.33 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.413 ' N ' HG13 ' A' ' 1' ' ' ILE . 0.7 OUTLIER -47.89 -27.76 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.459 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.21 81.41 0.34 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.4 Cg_exo -58.83 -24.39 71.78 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.609 2.206 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.8 -55.58 23.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.737 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -52.73 -26.7 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.808 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.07 -26.59 61.78 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.662 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 19.3 mt -74.9 -48.0 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.906 0.384 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.09 -41.77 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.863 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.29 -27.76 71.2 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -81.3 -44.33 17.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.09 -16.64 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.6 mt -73.08 -29.03 62.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.72 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 17' ' ' LEU . . . -88.53 -26.76 26.7 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -77.05 -33.24 46.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.692 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 37.3 tp -77.91 -30.14 50.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.0 110.698 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.548 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -77.29 -22.06 52.59 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.148 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.15 -49.16 78.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -178.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.681 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.34 -11.99 33.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 111.306 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.681 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.668 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.02 45.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . -93.41 -49.88 2.49 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.853 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 45.5 Cg_exo -56.28 -19.42 27.89 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.782 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.2 t -54.72 -55.46 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -26.78 6.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.877 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.58 -26.73 60.48 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.543 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.06 -48.57 17.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 41.8 t -62.23 -35.22 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.498 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -58.04 -25.78 57.29 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -53.37 35.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.141 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 -24.38 58.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.556 0.693 . . . . 0.0 110.3 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.498 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 11.3 mt -73.97 -28.22 61.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.044 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.6 -21.82 61.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.96 45.02 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.113 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 20.2 mt -77.8 -19.25 55.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.405 0.621 . . . . 0.0 110.184 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 6.7 tp -76.07 -22.58 55.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.63 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.61 -48.01 83.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.673 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.08 -11.19 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.883 0.373 . . . . 0.0 111.245 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.673 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 4.1 tp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.481 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.1 mt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.804 0.335 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.4 mt -136.06 40.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.0 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . 156.78 125.85 0.9 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.018 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.49 -23.52 39.64 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.471 2.114 . . . . 0.0 112.943 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.43 -55.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 3' ' ' GLY . 3.7 pp -55.47 -26.7 43.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.718 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.67 -31.17 60.85 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.02 -48.54 17.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.9 -31.86 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -61.66 -32.01 79.98 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -66.62 -51.47 55.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 109.899 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.78 -16.71 62.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.503 0.668 . . . . 0.0 110.149 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.47 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 8.4 mt -72.98 -28.31 62.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.97 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.3 -31.82 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.43 -36.17 45.16 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.633 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 15.6 mt -77.3 -15.11 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.509 HD11 HG22 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -74.54 -22.65 58.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.771 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.6 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.57 -47.68 80.54 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.303 -178.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.692 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.72 -13.74 28.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.279 179.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.692 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.519 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.2 mm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 2' ' ' ILE . 1.1 tp 43.32 54.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.742 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.413 ' N ' ' HD3' ' A' ' 4' ' ' PRO . . . -166.24 63.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.522 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 3' ' ' GLY . 22.2 Cg_exo -65.96 -12.23 34.44 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.755 2.303 . . . . 0.0 112.814 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' HA ' ' CG ' ' A' ' 8' ' ' LEU . 17.5 t -54.16 -55.39 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.83 -28.14 63.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.422 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.61 -38.88 15.64 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.852 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.473 ' CG ' ' HA ' ' A' ' 5' ' ' VAL . 1.5 pp -77.08 -48.0 19.01 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.209 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.406 ' N ' HD11 ' A' ' 8' ' ' LEU . 77.5 t -58.97 -31.91 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.94 0.4 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.33 -27.05 70.11 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.534 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -71.86 -47.84 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 -14.87 61.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.512 0.673 . . . . 0.0 110.069 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 mt -73.59 -28.83 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.989 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.61 -22.34 43.78 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.45 -41.95 50.19 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.801 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.504 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.46 -21.48 52.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.464 0.649 . . . . 0.0 109.757 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 20' ' ' ILE . 14.2 tp -76.55 -22.59 54.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.882 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.637 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.87 -49.81 74.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.124 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.16 -10.18 39.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.389 . . . . 0.0 111.354 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.709 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 5.0 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.677 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.7 t . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.96 -26.59 67.47 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.288 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -46.72 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.4 -17.98 62.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.586 0.707 . . . . 0.0 109.941 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.489 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.1 mt -73.58 -28.34 61.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.817 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.11 -26.48 28.53 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -74.92 -33.1 55.93 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.822 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -77.46 -25.86 50.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.396 0.617 . . . . 0.0 109.588 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.85 ' O ' HG22 ' A' ' 20' ' ' ILE . 35.7 mt -77.3 -22.28 52.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.282 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.629 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.18 -50.06 75.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.725 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.58 -11.71 33.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.213 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.8 tp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.732 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.691 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.31 -28.35 69.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.115 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 t -81.11 -44.98 17.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -69.96 -16.62 63.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.54 0.686 . . . . 0.0 109.708 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.691 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.2 mt -67.57 -28.56 67.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.86 -26.3 32.26 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -73.94 -40.7 43.19 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.676 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.4 mt -77.21 -15.85 59.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.33 0.586 . . . . 0.0 110.201 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.51 -24.05 50.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.062 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.689 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -55.24 -53.54 54.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.484 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.689 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -94.61 -24.65 17.11 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.734 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 17' ' ' LEU . 6.9 tp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.223 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 47.7 t . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.702 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -61.91 -28.96 71.13 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.302 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -44.41 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 -8.31 55.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.874 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.702 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.45 -29.03 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.126 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.485 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -85.76 -29.83 25.42 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' HE2' ' A' ' 18' ' ' LYS . . . -76.51 -32.48 50.94 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.302 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.53 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.3 tt -77.18 -19.69 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.271 0.557 . . . . 0.0 110.34 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.61 ' O ' HG22 ' A' ' 20' ' ' ILE . 26.0 mt -75.47 -22.14 57.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.65 -48.55 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.502 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.719 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.57 -12.31 34.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 111.06 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.719 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.618 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.96 0.41 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.653 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -64.62 -29.69 75.88 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.27 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -77.24 -46.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -71.56 -18.31 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.046 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.653 HD12 ' HA2' ' A' ' 10' ' ' GLY . 6.5 mt -68.14 -31.85 71.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.804 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.4 -28.15 23.12 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.59 -34.12 45.35 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.439 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.526 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.16 -23.68 51.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.208 0.528 . . . . 0.0 110.052 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.716 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.16 -23.19 51.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.633 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.74 -50.82 69.55 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.449 -178.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.33 -9.64 41.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.319 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.718 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.717 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.652 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -62.31 -27.66 69.65 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -45.63 20.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.67 -15.25 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 109.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.652 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.2 mt -69.5 -27.99 65.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.15 -30.61 16.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.48 -0.866 . . . . 0.0 110.959 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 18' ' ' LYS . . . -76.5 -32.38 51.29 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.234 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -80.06 -18.84 48.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.336 179.116 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.801 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -76.9 -23.75 52.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.015 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.561 ' CE ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.91 -46.75 89.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.011 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.754 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.45 -14.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 111.04 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.88 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.904 0.383 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -60.68 -25.86 64.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -44.41 21.25 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.05 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 109.783 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.588 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.4 mt -69.12 -28.4 66.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.766 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.35 -21.89 57.71 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.23 74.72 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.011 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.6 mp -77.14 -24.5 51.6 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.5 0.667 . . . . 0.0 109.623 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.893 HD12 HG21 ' A' ' 20' ' ' ILE . 11.6 tp -76.75 -22.58 53.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.707 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.66 -49.02 79.18 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.447 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.98 -11.39 36.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.0 0.428 . . . . 0.0 111.209 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.893 HG21 HD12 ' A' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.674 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.414 HG12 ' HG ' ' A' ' 13' ' ' LEU . 23.4 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.781 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.55 -29.19 71.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.361 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -81.79 -45.79 15.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.095 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -70.63 -15.14 62.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.485 0.66 . . . . 0.0 109.822 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.781 HD12 ' HA2' ' A' ' 10' ' ' GLY . 6.2 mt -67.99 -28.48 67.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.819 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.22 -25.36 37.14 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.56 21.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.768 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.699 HD23 ' NZ ' ' A' ' 19' ' ' LYS . 1.8 mt -77.04 -15.45 59.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.507 0.67 . . . . 0.0 109.987 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.889 HD12 HG21 ' A' ' 20' ' ' ILE . 9.0 tp -75.26 -22.39 57.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.459 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.673 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.96 -48.95 79.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.145 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.63 -11.02 35.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.889 HG21 HD12 ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -60.72 -26.18 64.59 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.2 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 m -69.79 -49.32 53.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.47 63.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.732 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 17' ' ' LEU . 5.5 mt -73.64 -28.39 61.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.831 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.86 -22.85 48.08 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.28 -40.78 54.76 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.83 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD23 ' HZ2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.27 -22.21 52.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 109.771 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 20' ' ' ILE . 21.6 mt -76.36 -22.51 54.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.668 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.2 -49.67 76.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.987 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.738 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.71 -10.85 35.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.908 0.385 . . . . 0.0 111.387 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.5 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.679 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.75 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -65.33 -27.99 73.07 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.3 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -46.24 40.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.11 -9.77 58.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.75 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.82 -29.55 62.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.56 -22.8 49.45 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.14 -43.55 39.2 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.79 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.33 -23.46 50.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 109.71 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.84 HD12 HG21 ' A' ' 20' ' ' ILE . 7.0 tp -76.78 -23.0 52.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.06 -49.24 78.66 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.367 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.96 -11.49 36.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.203 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.84 HG21 HD12 ' A' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.51 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.868 0.366 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.646 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -61.87 -25.97 66.54 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.31 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -80.87 -44.6 18.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 -8.69 56.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.117 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.646 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.64 -31.66 63.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.27 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.2 -30.7 16.07 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.53 -33.36 48.03 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.223 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.496 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -77.19 -20.39 55.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.876 ' O ' HG22 ' A' ' 20' ' ' ILE . 18.6 mt -76.55 -22.55 54.2 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.062 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.19 -49.3 78.19 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.023 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.722 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.68 -10.91 35.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.262 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.876 HG22 ' O ' ' A' ' 17' ' ' LEU . 2.0 tt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.669 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.619 HG12 ' CD1' ' A' ' 13' ' ' LEU . 46.2 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.19 69.58 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.178 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.7 m -75.05 -48.36 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.59 -16.92 60.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 17' ' ' LEU . 8.5 mt -74.03 -31.52 62.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.38 -29.85 18.16 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.49 -33.79 46.86 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.089 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 4.8 tt -77.33 -20.9 54.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.066 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 20' ' ' ILE . 4.3 mt -76.73 -22.61 53.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.58 -48.43 81.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.697 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.35 -11.01 36.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.22 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.943 HG21 HD23 ' A' ' 17' ' ' LEU . 9.2 tt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.616 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.75 -28.45 70.04 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.11 -49.24 52.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.007 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 -16.05 61.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.635 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 mt -73.66 -33.92 64.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.29 -27.48 27.77 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.24 -31.35 55.18 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.932 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.628 HD23 ' HE3' ' A' ' 19' ' ' LYS . 4.1 mt -77.09 -25.64 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 109.681 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.882 ' O ' HG22 ' A' ' 20' ' ' ILE . 18.1 mt -76.25 -22.1 55.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.791 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.89 -48.42 81.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.164 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.07 -11.57 35.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.174 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.882 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.1 tt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.282 -0.865 . . . . 0.0 111.69 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.3 t . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.781 0.324 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.693 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -62.19 -25.8 66.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.353 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -79.78 -45.26 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -8.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.255 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.693 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.95 -37.6 64.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.34 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.35 -26.34 30.85 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.26 -41.0 27.42 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.828 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -77.48 -20.05 54.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.358 0.599 . . . . 0.0 109.865 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.898 HD12 HG21 ' A' ' 20' ' ' ILE . 16.1 tp -76.86 -22.56 53.31 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.646 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.02 -50.09 73.42 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.372 -178.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.55 -11.32 34.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.898 HG21 HD12 ' A' ' 17' ' ' LEU . 7.3 tp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.754 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.543 HG12 ' CD1' ' A' ' 13' ' ' LEU . 46.4 t . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -62.46 -28.14 70.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -73.78 -49.16 26.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.5 -17.53 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.514 0.673 . . . . 0.0 110.164 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.543 ' CD1' HG12 ' A' ' 9' ' ' VAL . 9.1 mt -73.67 -28.23 61.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.852 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.3 -24.91 38.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.7 -38.9 41.78 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.033 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.831 HD13 ' HE3' ' A' ' 19' ' ' LYS . 4.2 mm? -77.4 -19.79 55.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.297 0.57 . . . . 0.0 110.006 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.1 tm? -75.77 -23.88 55.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.635 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.673 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.84 -50.27 72.93 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.68 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.831 ' HE3' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -92.34 -11.39 35.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.529 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.867 HG21 HD22 ' A' ' 17' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.785 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG12 ' HG ' ' A' ' 13' ' ' LEU . 51.6 t . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.953 0.406 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.57 -26.22 66.32 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.331 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.23 -48.52 28.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.037 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.94 -16.18 61.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.481 0.658 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 17' ' ' LEU . 9.8 mt -73.52 -28.66 62.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.959 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.23 -21.88 47.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.15 -38.33 35.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.29 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 5.3 mt -77.44 -23.32 50.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.33 0.586 . . . . 0.0 110.01 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.861 ' O ' HG22 ' A' ' 20' ' ' ILE . 41.1 mt -76.65 -22.4 54.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.46 -49.45 77.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.034 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.73 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.38 -10.14 39.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.358 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.861 HG22 ' O ' ' A' ' 17' ' ' LEU . 4.5 tt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.653 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.781 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -63.63 -27.0 70.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.308 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -74.41 -46.89 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.26 -9.26 58.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.144 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.781 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.83 -32.76 63.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.275 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . -83.21 -24.93 50.22 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.86 -47.22 77.09 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.49 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 9.0 mp -76.95 -16.53 59.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.64 0.733 . . . . 0.0 109.442 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.834 ' O ' HG22 ' A' ' 20' ' ' ILE . 6.6 tt -75.55 -22.76 56.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.729 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.659 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.4 -49.16 78.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.105 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.3 -10.26 39.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.38 . . . . 0.0 111.321 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.259 -0.876 . . . . 0.0 111.602 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -63.29 -27.76 71.2 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -81.3 -44.33 17.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.09 -16.64 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.601 HD12 ' HA2' ' A' ' 10' ' ' GLY . 8.6 mt -73.08 -29.03 62.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.72 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 17' ' ' LEU . . . -88.53 -26.76 26.7 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -77.05 -33.24 46.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.692 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.654 HD12 ' HE3' ' A' ' 19' ' ' LYS . 37.3 tp -77.91 -30.14 50.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.0 110.698 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -77.29 -22.06 52.59 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.148 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.15 -49.16 78.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -178.527 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.34 -11.99 33.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 111.306 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.668 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.66 HG12 ' CD1' ' A' ' 13' ' ' LEU . 41.8 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -58.04 -25.78 57.29 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -53.37 35.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.141 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 -24.38 58.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.556 0.693 . . . . 0.0 110.3 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.66 ' CD1' HG12 ' A' ' 9' ' ' VAL . 11.3 mt -73.97 -28.22 61.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.044 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.6 -21.82 61.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.96 45.02 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.113 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.486 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 20.2 mt -77.8 -19.25 55.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.405 0.621 . . . . 0.0 110.184 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.896 ' O ' HG22 ' A' ' 20' ' ' ILE . 6.7 tp -76.07 -22.58 55.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.61 -48.01 83.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.701 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.08 -11.19 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.883 0.373 . . . . 0.0 111.245 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.896 HG22 ' O ' ' A' ' 17' ' ' LEU . 4.1 tp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.481 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.66 -32.01 79.98 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -66.62 -51.47 55.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 109.899 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -70.78 -16.71 62.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.503 0.668 . . . . 0.0 110.149 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.56 HD12 ' HA2' ' A' ' 10' ' ' GLY . 8.4 mt -72.98 -28.31 62.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.97 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.3 -31.82 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.43 -36.17 45.16 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.633 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.503 HD23 ' HE3' ' A' ' 19' ' ' LYS . 15.6 mt -77.3 -15.11 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.618 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -74.54 -22.65 58.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.771 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.57 -47.68 80.54 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.303 -178.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.72 -13.74 28.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.279 179.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.718 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.519 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.5 t . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.94 0.4 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.59 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -63.33 -27.05 70.11 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.534 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -71.86 -47.84 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 -14.87 61.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.512 0.673 . . . . 0.0 110.069 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.59 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.7 mt -73.59 -28.83 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.989 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.61 -22.34 43.78 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.45 -41.95 50.19 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.801 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.46 -21.48 52.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.464 0.649 . . . . 0.0 109.757 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.938 HD12 HG21 ' A' ' 20' ' ' ILE . 14.2 tp -76.55 -22.59 54.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.882 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.87 -49.81 74.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.124 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.16 -10.18 39.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.389 . . . . 0.0 111.354 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.938 HG21 HD12 ' A' ' 17' ' ' LEU . 5.0 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.677 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.886 0.374 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.57 -33.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.489 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.78 99.06 0.19 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.76 -17.88 52.71 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.58 2.187 . . . . 0.0 112.573 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 18.0 t -63.47 -53.86 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.64 -27.77 65.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.264 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.41 -36.65 23.07 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 9' ' ' VAL . 2.0 pp -74.71 -44.57 49.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.06 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.7 t -62.34 -38.67 81.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.956 0.408 . . . . 0.0 109.949 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.96 -26.59 67.47 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.288 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -46.72 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.4 -17.98 62.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.586 0.707 . . . . 0.0 109.941 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.489 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.1 mt -73.58 -28.34 61.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.817 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.11 -26.48 28.53 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -74.92 -33.1 55.93 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.822 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -77.46 -25.86 50.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.396 0.617 . . . . 0.0 109.588 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.85 ' O ' HG22 ' A' ' 20' ' ' ILE . 35.7 mt -77.3 -22.28 52.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.282 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.629 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.18 -50.06 75.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.725 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.58 -11.71 33.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.213 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.8 tp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.732 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.961 0.41 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.402 ' CD1' ' HD2' ' A' ' 4' ' ' PRO . 5.1 pt -90.57 -25.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.461 ' O ' HD23 ' A' ' 6' ' ' LEU . . . 145.9 -70.53 0.37 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.633 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 18.3 Cg_exo -67.66 1.13 3.42 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.918 2.412 . . . . 0.0 113.357 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.28 -55.08 11.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.815 0.34 . . . . 0.0 111.062 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER -50.51 -27.56 6.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.558 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.9 -30.55 47.08 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 23.6 mt -75.74 -48.13 23.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.956 0.408 . . . . 0.0 109.941 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.64 -41.92 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.352 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.691 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.31 -28.35 69.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.115 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 t -81.11 -44.98 17.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -69.96 -16.62 63.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.54 0.686 . . . . 0.0 109.708 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.691 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.2 mt -67.57 -28.56 67.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.86 -26.3 32.26 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -73.94 -40.7 43.19 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.676 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.4 mt -77.21 -15.85 59.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.33 0.586 . . . . 0.0 110.201 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.51 -24.05 50.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.062 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.689 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -55.24 -53.54 54.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.484 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.689 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -94.61 -24.65 17.11 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.734 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 17' ' ' LEU . 6.9 tp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.223 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 3' ' ' GLY . 2.8 mt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.18 -20.89 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.397 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 1' ' ' ILE . . . 89.11 99.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.352 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.11 7.85 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.539 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -52.93 -55.55 11.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.67 -26.99 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.75 -27.07 65.69 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.216 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.06 -48.15 18.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.899 0.381 . . . . 0.0 110.342 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 47.7 t -59.7 -39.79 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.112 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.702 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -61.91 -28.96 71.13 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.302 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -44.41 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 -8.31 55.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.874 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.702 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.45 -29.03 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.126 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -85.76 -29.83 25.42 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' HE2' ' A' ' 18' ' ' LYS . . . -76.51 -32.48 50.94 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.302 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.53 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.3 tt -77.18 -19.69 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.271 0.557 . . . . 0.0 110.34 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.61 ' O ' HG22 ' A' ' 20' ' ' ILE . 26.0 mt -75.47 -22.14 57.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.65 -48.55 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.502 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.719 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.57 -12.31 34.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 111.06 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.719 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.618 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.7 pt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.826 0.346 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 2' ' ' ILE . 4.7 mt -86.28 58.63 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.084 0.469 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.32 71.22 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.27 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.28 0.6 5.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.138 2.558 . . . . 0.0 113.267 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' HD21 ' A' ' 8' ' ' LEU . 16.6 t -53.32 -55.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -28.5 64.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.459 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.92 -39.6 13.14 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.94 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 9' ' ' VAL . 2.5 pp -77.14 -48.37 17.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.116 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' N ' HD12 ' A' ' 8' ' ' LEU . 60.3 t -62.24 -34.82 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 110.033 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.653 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -64.62 -29.69 75.88 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.27 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -77.24 -46.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -71.56 -18.31 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.046 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.653 HD12 ' HA2' ' A' ' 10' ' ' GLY . 6.5 mt -68.14 -31.85 71.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.804 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.4 -28.15 23.12 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.59 -34.12 45.35 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.439 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.526 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.16 -23.68 51.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.208 0.528 . . . . 0.0 110.052 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.716 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.16 -23.19 51.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.633 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.74 -50.82 69.55 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.449 -178.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.33 -9.64 41.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.319 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.718 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.717 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 3' ' ' GLY . 3.3 mp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.98 -33.2 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.714 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.577 ' H ' HG22 ' A' ' 1' ' ' ILE . . . -128.22 85.51 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.131 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.58 -9.16 17.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.876 2.384 . . . . 0.0 113.322 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 16.2 t -56.54 -53.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 0.0 110.835 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.53 -27.44 69.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.12 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.47 -35.38 26.2 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 9' ' ' VAL . 4.1 pp -73.63 -43.96 58.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.817 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.657 ' N ' HD12 ' A' ' 8' ' ' LEU . 89.3 t -64.07 -40.22 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.652 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -62.31 -27.66 69.65 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -45.63 20.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.67 -15.25 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 109.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.652 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.2 mt -69.5 -27.99 65.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.15 -30.61 16.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.48 -0.866 . . . . 0.0 110.959 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 18' ' ' LYS . . . -76.5 -32.38 51.29 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.234 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -80.06 -18.84 48.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.336 179.116 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.801 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -76.9 -23.75 52.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.015 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.561 ' CE ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.91 -46.75 89.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.011 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.754 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.45 -14.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 111.04 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.88 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.78 0.324 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.11 -39.92 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.5 85.76 0.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.358 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 27.4 Cg_exo -62.07 -13.76 33.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.729 2.286 . . . . 0.0 112.754 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.42 -55.33 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 pp -49.33 -27.49 3.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.879 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.04 -31.51 42.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.263 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 21.8 mt -77.19 -48.41 17.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.882 0.372 . . . . 0.0 110.383 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.11 -41.04 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.439 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -60.68 -25.86 64.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -44.41 21.25 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.05 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 109.783 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.588 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.4 mt -69.12 -28.4 66.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.766 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.35 -21.89 57.71 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.23 74.72 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.011 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.6 mp -77.14 -24.5 51.6 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.5 0.667 . . . . 0.0 109.623 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.893 HD12 HG21 ' A' ' 20' ' ' ILE . 11.6 tp -76.75 -22.58 53.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.707 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.66 -49.02 79.18 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.447 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.98 -11.39 36.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.0 0.428 . . . . 0.0 111.209 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.893 HG21 HD12 ' A' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.674 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 mp 65.29 95.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.86 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.78 -12.12 30.06 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.787 2.325 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.631 HG12 ' CG2' ' A' ' 9' ' ' VAL . 15.6 t -53.88 -55.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 mt -47.34 -27.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.044 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.36 -36.36 27.16 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.13 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.53 -46.78 21.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.631 ' CG2' HG12 ' A' ' 5' ' ' VAL . 23.4 t -54.94 -35.87 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.781 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.55 -29.19 71.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.361 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -81.79 -45.79 15.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.095 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -70.63 -15.14 62.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.485 0.66 . . . . 0.0 109.822 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.781 HD12 ' HA2' ' A' ' 10' ' ' GLY . 6.2 mt -67.99 -28.48 67.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.819 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.22 -25.36 37.14 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.56 21.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.768 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.699 HD23 ' NZ ' ' A' ' 19' ' ' LYS . 1.8 mt -77.04 -15.45 59.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.507 0.67 . . . . 0.0 109.987 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.889 HD12 HG21 ' A' ' 20' ' ' ILE . 9.0 tp -75.26 -22.39 57.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.459 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.673 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.96 -48.95 79.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.145 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.63 -11.02 35.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.889 HG21 HD12 ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pt -97.78 19.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.382 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 4' ' ' PRO . . . 134.28 124.79 2.51 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.612 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 3' ' ' GLY . 19.9 Cg_exo -67.24 -0.85 5.41 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.797 2.331 . . . . 0.0 113.291 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.701 ' HA ' HD23 ' A' ' 8' ' ' LEU . 61.5 t -53.28 -55.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.39 -28.32 69.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.461 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.66 -25.46 58.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.497 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.701 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -77.31 -43.14 34.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 43.7 t -69.26 -34.71 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -60.72 -26.18 64.59 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.2 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 m -69.79 -49.32 53.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.47 63.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.732 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 17' ' ' LEU . 5.5 mt -73.64 -28.39 61.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.831 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.86 -22.85 48.08 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.28 -40.78 54.76 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.83 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD23 ' HZ2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.27 -22.21 52.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 109.771 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 20' ' ' ILE . 21.6 mt -76.36 -22.51 54.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.668 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.2 -49.67 76.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.987 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.738 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.71 -10.85 35.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.908 0.385 . . . . 0.0 111.387 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.5 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.679 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 2' ' ' ILE . 1.7 mt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.794 0.33 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.478 ' N ' HG22 ' A' ' 1' ' ' ILE . 1.0 OUTLIER -87.46 89.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.199 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . 173.99 -50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.772 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 38.4 Cg_exo -60.19 -14.77 30.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.627 2.218 . . . . 0.0 112.881 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.754 ' HA ' HD23 ' A' ' 8' ' ' LEU . 21.5 t -55.6 -55.61 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.78 -28.57 67.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.575 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.73 38.26 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.513 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.754 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -77.15 -44.23 31.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.661 0.267 . . . . 0.0 110.336 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.554 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 51.8 t -70.07 -33.86 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.75 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -65.33 -27.99 73.07 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.3 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -46.24 40.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.11 -9.77 58.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.75 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.82 -29.55 62.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.56 -22.8 49.45 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.14 -43.55 39.2 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.79 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.33 -23.46 50.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 109.71 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.84 HD12 HG21 ' A' ' 20' ' ' ILE . 7.0 tp -76.78 -23.0 52.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.06 -49.24 78.66 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.367 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.96 -11.49 36.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.203 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.84 HG21 HD12 ' A' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.51 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.605 ' N ' HD13 ' A' ' 1' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.481 ' N ' HG12 ' A' ' 1' ' ' ILE . 2.2 mp 65.75 73.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.137 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.37 91.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 33.4 Cg_exo -59.29 -19.25 49.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.605 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -56.93 -55.3 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.26 -27.18 3.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.104 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.31 -28.09 56.44 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.63 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 11.8 mt -77.21 -48.45 17.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.927 0.394 . . . . 0.0 110.478 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.21 -41.58 84.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.226 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.646 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -61.87 -25.97 66.54 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.31 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -80.87 -44.6 18.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 -8.69 56.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.117 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.646 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.64 -31.66 63.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.27 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.2 -30.7 16.07 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.53 -33.36 48.03 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.223 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.496 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -77.19 -20.39 55.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.876 ' O ' HG22 ' A' ' 20' ' ' ILE . 18.6 mt -76.55 -22.55 54.2 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.062 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.19 -49.3 78.19 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.023 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.722 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.68 -10.91 35.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.262 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.876 HG22 ' O ' ' A' ' 17' ' ' LEU . 2.0 tt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.669 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.79 0.328 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 pt -87.41 9.03 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.386 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.28 101.32 1.54 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.374 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.39 -21.29 36.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.519 2.146 . . . . 0.0 112.622 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.875 ' HA ' HD23 ' A' ' 8' ' ' LEU . 22.0 t -66.03 -55.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.751 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mt -60.19 -28.3 67.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.632 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.71 -29.46 47.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.55 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.875 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -77.14 -42.11 39.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 110.551 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.619 HG12 ' CD1' ' A' ' 13' ' ' LEU . 46.2 t -67.98 -35.58 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.19 69.58 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.178 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.7 m -75.05 -48.36 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.59 -16.92 60.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 17' ' ' LEU . 8.5 mt -74.03 -31.52 62.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.38 -29.85 18.16 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.49 -33.79 46.86 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.089 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 4.8 tt -77.33 -20.9 54.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.066 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 20' ' ' ILE . 4.3 mt -76.73 -22.61 53.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.58 -48.43 81.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.697 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.35 -11.01 36.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.22 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.943 HG21 HD23 ' A' ' 17' ' ' LEU . 9.2 tt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.616 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.922 0.391 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 pt -100.24 84.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.222 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.37 88.79 0.54 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.537 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.96 -18.17 55.79 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.545 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.45 -55.38 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.99 -26.96 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.734 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.81 -27.17 67.5 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.1 mt -75.94 -48.19 22.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.947 0.403 . . . . 0.0 109.995 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.03 -33.66 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.75 -28.45 70.04 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.11 -49.24 52.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.007 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 -16.05 61.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.635 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 mt -73.66 -33.92 64.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.29 -27.48 27.77 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.24 -31.35 55.18 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.932 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.628 HD23 ' HE3' ' A' ' 19' ' ' LYS . 4.1 mt -77.09 -25.64 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 109.681 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.882 ' O ' HG22 ' A' ' 20' ' ' ILE . 18.1 mt -76.25 -22.1 55.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.791 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.89 -48.42 81.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.164 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.07 -11.57 35.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.174 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.882 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.1 tt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.282 -0.865 . . . . 0.0 111.69 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.633 HG22 HG13 ' A' ' 2' ' ' ILE . 28.8 mt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.866 0.365 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.633 HG13 HG22 ' A' ' 1' ' ' ILE . 16.8 mt 68.92 -66.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.134 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.74 122.16 0.6 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.65 -13.55 26.58 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 112.77 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' HA ' HD23 ' A' ' 8' ' ' LEU . 17.7 t -61.64 -56.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.8 pp -57.52 -27.88 62.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.38 -35.84 25.3 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.298 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 5' ' ' VAL . 1.2 pp -77.47 -40.75 42.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.3 t -64.46 -41.49 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.288 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.693 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -62.19 -25.8 66.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.353 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -79.78 -45.26 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -8.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.255 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.693 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.95 -37.6 64.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.34 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.35 -26.34 30.85 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.26 -41.0 27.42 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.828 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -77.48 -20.05 54.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.358 0.599 . . . . 0.0 109.865 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.898 HD12 HG21 ' A' ' 20' ' ' ILE . 16.1 tp -76.86 -22.56 53.31 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.646 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.02 -50.09 73.42 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.372 -178.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.55 -11.32 34.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.898 HG21 HD12 ' A' ' 17' ' ' LEU . 7.3 tp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.754 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.888 0.375 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 pt -97.98 34.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.03 102.07 0.01 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.03 -14.87 44.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.64 2.227 . . . . 0.0 112.683 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -54.29 -55.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -26.86 11.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.868 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.93 61.59 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.559 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 mt -75.35 -48.32 23.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.835 0.35 . . . . 0.0 110.067 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.543 HG12 ' CD1' ' A' ' 13' ' ' LEU . 46.4 t -65.33 -35.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -62.46 -28.14 70.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -73.78 -49.16 26.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.5 -17.53 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.514 0.673 . . . . 0.0 110.164 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.543 ' CD1' HG12 ' A' ' 9' ' ' VAL . 9.1 mt -73.67 -28.23 61.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.852 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.3 -24.91 38.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.7 -38.9 41.78 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.033 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.831 HD13 ' HE3' ' A' ' 19' ' ' LYS . 4.2 mm? -77.4 -19.79 55.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.297 0.57 . . . . 0.0 110.006 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.1 tm? -75.77 -23.88 55.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.635 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.673 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.84 -50.27 72.93 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.68 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.831 ' HE3' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -92.34 -11.39 35.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.529 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.867 HG21 HD22 ' A' ' 17' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.785 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.6 pt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 2' ' ' ILE . 4.0 mp -142.62 51.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.23 -88.99 0.89 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.685 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.02 -16.07 43.19 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.618 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.684 ' O ' HG23 ' A' ' 9' ' ' VAL . 28.3 t -58.66 -55.42 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 mt -58.18 -28.43 64.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.425 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.16 -40.53 11.32 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.01 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 9' ' ' VAL . 3.8 pp -77.48 -44.32 29.26 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.245 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 5' ' ' VAL . 51.6 t -58.9 -35.62 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 110.307 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.57 -26.22 66.32 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.331 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.23 -48.52 28.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.037 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.94 -16.18 61.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.481 0.658 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 17' ' ' LEU . 9.8 mt -73.52 -28.66 62.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.959 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.23 -21.88 47.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.15 -38.33 35.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.29 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 5.3 mt -77.44 -23.32 50.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.33 0.586 . . . . 0.0 110.01 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.861 ' O ' HG22 ' A' ' 20' ' ' ILE . 41.1 mt -76.65 -22.4 54.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.46 -49.45 77.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.034 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.73 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.38 -10.14 39.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.358 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.861 HG22 ' O ' ' A' ' 17' ' ' LEU . 4.5 tt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.653 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.647 ' N ' HD13 ' A' ' 1' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.818 0.342 . . . . 0.0 111.126 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.863 HG22 HG23 ' A' ' 5' ' ' VAL . 12.8 mm -71.69 90.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . -76.67 -41.41 24.28 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.371 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 79.7 Cg_exo -45.37 -26.85 2.82 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.459 2.106 . . . . 0.0 113.139 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.863 HG23 HG22 ' A' ' 2' ' ' ILE . 29.5 t -59.09 -55.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.986 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pp -49.99 -26.98 4.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.021 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.78 -27.76 58.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.653 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.12 -48.51 17.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.868 0.366 . . . . 0.0 110.355 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.43 -35.18 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.781 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -63.63 -27.0 70.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.308 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -74.41 -46.89 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.26 -9.26 58.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.144 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.781 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.83 -32.76 63.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.275 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . -83.21 -24.93 50.22 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.86 -47.22 77.09 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.49 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 9.0 mp -76.95 -16.53 59.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.64 0.733 . . . . 0.0 109.442 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.834 ' O ' HG22 ' A' ' 20' ' ' ILE . 6.6 tt -75.55 -22.76 56.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.729 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.659 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.4 -49.16 78.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.105 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.3 -10.26 39.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.38 . . . . 0.0 111.321 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.259 -0.876 . . . . 0.0 111.602 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 2' ' ' ILE . 10.4 tp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.793 0.33 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' N ' HG13 ' A' ' 1' ' ' ILE . 0.7 OUTLIER -47.89 -27.76 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.459 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.21 81.41 0.34 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.4 Cg_exo -58.83 -24.39 71.78 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.609 2.206 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.8 -55.58 23.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.737 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -52.73 -26.7 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.808 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.07 -26.59 61.78 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.662 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 19.3 mt -74.9 -48.0 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.906 0.384 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.09 -41.77 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.863 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -63.29 -27.76 71.2 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -81.3 -44.33 17.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.09 -16.64 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.601 HD12 ' HA2' ' A' ' 10' ' ' GLY . 8.6 mt -73.08 -29.03 62.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.72 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 17' ' ' LEU . . . -88.53 -26.76 26.7 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -77.05 -33.24 46.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.692 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.654 HD12 ' HE3' ' A' ' 19' ' ' LYS . 37.3 tp -77.91 -30.14 50.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.0 110.698 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -77.29 -22.06 52.59 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.148 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.15 -49.16 78.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -178.527 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.34 -11.99 33.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 111.306 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.668 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.705 ' CG2' HG21 ' A' ' 5' ' ' VAL . 1.6 mp -93.02 45.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . -93.41 -49.88 2.49 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.853 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 45.5 Cg_exo -56.28 -19.42 27.89 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.782 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.705 HG21 ' CG2' ' A' ' 2' ' ' ILE . 18.2 t -54.72 -55.46 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -26.78 6.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.877 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.58 -26.73 60.48 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.543 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.06 -48.57 17.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.66 HG12 ' CD1' ' A' ' 13' ' ' LEU . 41.8 t -62.23 -35.22 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -58.04 -25.78 57.29 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -53.37 35.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.141 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 -24.38 58.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.556 0.693 . . . . 0.0 110.3 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.66 ' CD1' HG12 ' A' ' 9' ' ' VAL . 11.3 mt -73.97 -28.22 61.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.044 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.6 -21.82 61.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.96 45.02 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.113 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.486 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 20.2 mt -77.8 -19.25 55.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.405 0.621 . . . . 0.0 110.184 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.896 ' O ' HG22 ' A' ' 20' ' ' ILE . 6.7 tp -76.07 -22.58 55.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.61 -48.01 83.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.701 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.08 -11.19 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.883 0.373 . . . . 0.0 111.245 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.896 HG22 ' O ' ' A' ' 17' ' ' LEU . 4.1 tp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.481 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.786 HG22 HG13 ' A' ' 2' ' ' ILE . 4.1 mt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.804 0.335 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.786 HG13 HG22 ' A' ' 1' ' ' ILE . 14.4 mt -136.06 40.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.0 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . 156.78 125.85 0.9 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.018 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.49 -23.52 39.64 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.471 2.114 . . . . 0.0 112.943 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.43 -55.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.7 pp -55.47 -26.7 43.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.718 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.67 -31.17 60.85 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.02 -48.54 17.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.9 -31.86 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.66 -32.01 79.98 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -66.62 -51.47 55.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 109.899 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -70.78 -16.71 62.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.503 0.668 . . . . 0.0 110.149 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.56 HD12 ' HA2' ' A' ' 10' ' ' GLY . 8.4 mt -72.98 -28.31 62.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.97 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.3 -31.82 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.43 -36.17 45.16 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.633 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.503 HD23 ' HE3' ' A' ' 19' ' ' LYS . 15.6 mt -77.3 -15.11 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.618 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -74.54 -22.65 58.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.771 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.57 -47.68 80.54 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.303 -178.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.72 -13.74 28.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.279 179.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.718 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.519 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.2 mm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 2' ' ' ILE . 1.1 tp 43.32 54.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.742 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.42 ' N ' ' HD3' ' A' ' 4' ' ' PRO . . . -166.24 63.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.522 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 3' ' ' GLY . 22.2 Cg_exo -65.96 -12.23 34.44 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.755 2.303 . . . . 0.0 112.814 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HA ' ' CG ' ' A' ' 8' ' ' LEU . 17.5 t -54.16 -55.39 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.83 -28.14 63.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.422 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.61 -38.88 15.64 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.852 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 9' ' ' VAL . 1.5 pp -77.08 -48.0 19.01 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.209 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.5 t -58.97 -31.91 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.94 0.4 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.59 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -63.33 -27.05 70.11 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.534 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -71.86 -47.84 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 -14.87 61.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.512 0.673 . . . . 0.0 110.069 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.59 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.7 mt -73.59 -28.83 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.989 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.61 -22.34 43.78 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.45 -41.95 50.19 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.801 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.46 -21.48 52.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.464 0.649 . . . . 0.0 109.757 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.938 HD12 HG21 ' A' ' 20' ' ' ILE . 14.2 tp -76.55 -22.59 54.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.882 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.87 -49.81 74.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.124 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.16 -10.18 39.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.389 . . . . 0.0 111.354 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.938 HG21 HD12 ' A' ' 17' ' ' LEU . 5.0 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.677 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.7 t . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.96 -26.59 67.47 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.288 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -46.72 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.4 -17.98 62.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.586 0.707 . . . . 0.0 109.941 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.489 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.1 mt -73.58 -28.34 61.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.817 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.11 -26.48 28.53 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -74.92 -33.1 55.93 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.822 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -77.46 -25.86 50.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.396 0.617 . . . . 0.0 109.588 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.85 ' O ' HG22 ' A' ' 20' ' ' ILE . 35.7 mt -77.3 -22.28 52.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.282 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.629 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.18 -50.06 75.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.725 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.58 -11.71 33.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.213 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.8 tp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.732 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.855 0.36 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.691 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.31 -28.35 69.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.115 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 t -81.11 -44.98 17.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -69.96 -16.62 63.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.54 0.686 . . . . 0.0 109.708 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.691 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.2 mt -67.57 -28.56 67.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.86 -26.3 32.26 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -73.94 -40.7 43.19 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.676 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.4 mt -77.21 -15.85 59.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.33 0.586 . . . . 0.0 110.201 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.51 -24.05 50.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.062 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.689 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -55.24 -53.54 54.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.484 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.689 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -94.61 -24.65 17.11 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.734 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 17' ' ' LEU . 6.9 tp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.223 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 47.7 t . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.917 0.389 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.702 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -61.91 -28.96 71.13 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.302 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -44.41 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 -8.31 55.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.874 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.702 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.45 -29.03 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.126 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.485 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -85.76 -29.83 25.42 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' HE2' ' A' ' 18' ' ' LYS . . . -76.51 -32.48 50.94 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.302 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.53 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.3 tt -77.18 -19.69 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.271 0.557 . . . . 0.0 110.34 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.61 ' O ' HG22 ' A' ' 20' ' ' ILE . 26.0 mt -75.47 -22.14 57.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.65 -48.55 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.502 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.719 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.57 -12.31 34.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 111.06 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.719 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.618 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.96 0.41 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.653 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -64.62 -29.69 75.88 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.27 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -77.24 -46.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -71.56 -18.31 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.046 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.653 HD12 ' HA2' ' A' ' 10' ' ' GLY . 6.5 mt -68.14 -31.85 71.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.804 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.4 -28.15 23.12 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.59 -34.12 45.35 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.439 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.526 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.16 -23.68 51.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.208 0.528 . . . . 0.0 110.052 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.716 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.16 -23.19 51.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.633 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.74 -50.82 69.55 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.449 -178.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.33 -9.64 41.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.319 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.718 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.717 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 89.3 t . . . . . 0 N--CA 1.456 -0.164 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.652 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -62.31 -27.66 69.65 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -45.63 20.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.67 -15.25 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 109.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.652 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.2 mt -69.5 -27.99 65.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.15 -30.61 16.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.48 -0.866 . . . . 0.0 110.959 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 18' ' ' LYS . . . -76.5 -32.38 51.29 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.234 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -80.06 -18.84 48.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.336 179.116 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.801 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -76.9 -23.75 52.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.015 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.561 ' CE ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.91 -46.75 89.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.011 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.754 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.45 -14.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 111.04 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.88 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.904 0.383 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -60.68 -25.86 64.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -44.41 21.25 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.05 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 109.783 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.588 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.4 mt -69.12 -28.4 66.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.766 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.35 -21.89 57.71 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.23 74.72 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.011 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.6 mp -77.14 -24.5 51.6 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.5 0.667 . . . . 0.0 109.623 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.893 HD12 HG21 ' A' ' 20' ' ' ILE . 11.6 tp -76.75 -22.58 53.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.707 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.66 -49.02 79.18 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.447 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.98 -11.39 36.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.0 0.428 . . . . 0.0 111.209 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.893 HG21 HD12 ' A' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.674 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.414 HG12 ' HG ' ' A' ' 13' ' ' LEU . 23.4 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.781 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.55 -29.19 71.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.361 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -81.79 -45.79 15.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.095 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -70.63 -15.14 62.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.485 0.66 . . . . 0.0 109.822 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.781 HD12 ' HA2' ' A' ' 10' ' ' GLY . 6.2 mt -67.99 -28.48 67.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.819 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.22 -25.36 37.14 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.56 21.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.768 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.699 HD23 ' NZ ' ' A' ' 19' ' ' LYS . 1.8 mt -77.04 -15.45 59.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.507 0.67 . . . . 0.0 109.987 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.889 HD12 HG21 ' A' ' 20' ' ' ILE . 9.0 tp -75.26 -22.39 57.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.459 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.673 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.96 -48.95 79.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.145 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.63 -11.02 35.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.889 HG21 HD12 ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -60.72 -26.18 64.59 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.2 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 m -69.79 -49.32 53.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.47 63.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.732 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 17' ' ' LEU . 5.5 mt -73.64 -28.39 61.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.831 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.86 -22.85 48.08 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.28 -40.78 54.76 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.83 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD23 ' HZ2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.27 -22.21 52.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 109.771 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 20' ' ' ILE . 21.6 mt -76.36 -22.51 54.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.668 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.2 -49.67 76.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.987 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.738 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.71 -10.85 35.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.908 0.385 . . . . 0.0 111.387 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.5 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.679 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.75 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -65.33 -27.99 73.07 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.3 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -46.24 40.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.11 -9.77 58.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.75 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.82 -29.55 62.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.56 -22.8 49.45 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.14 -43.55 39.2 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.79 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.33 -23.46 50.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 109.71 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.84 HD12 HG21 ' A' ' 20' ' ' ILE . 7.0 tp -76.78 -23.0 52.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.06 -49.24 78.66 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.367 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.96 -11.49 36.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.203 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.84 HG21 HD12 ' A' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.51 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.868 0.366 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.646 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -61.87 -25.97 66.54 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.31 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -80.87 -44.6 18.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 -8.69 56.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.117 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.646 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.64 -31.66 63.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.27 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.2 -30.7 16.07 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.53 -33.36 48.03 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.223 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.496 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -77.19 -20.39 55.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.876 ' O ' HG22 ' A' ' 20' ' ' ILE . 18.6 mt -76.55 -22.55 54.2 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.062 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.19 -49.3 78.19 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.023 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.722 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.68 -10.91 35.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.262 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.876 HG22 ' O ' ' A' ' 17' ' ' LEU . 2.0 tt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.669 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.619 HG12 ' CD1' ' A' ' 13' ' ' LEU . 46.2 t . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.19 69.58 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.178 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.7 m -75.05 -48.36 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.59 -16.92 60.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 17' ' ' LEU . 8.5 mt -74.03 -31.52 62.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.38 -29.85 18.16 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.49 -33.79 46.86 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.089 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 4.8 tt -77.33 -20.9 54.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.066 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 20' ' ' ILE . 4.3 mt -76.73 -22.61 53.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.58 -48.43 81.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.697 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.35 -11.01 36.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.22 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.943 HG21 HD23 ' A' ' 17' ' ' LEU . 9.2 tt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.616 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.75 -28.45 70.04 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.11 -49.24 52.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.007 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 -16.05 61.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.635 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 mt -73.66 -33.92 64.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.29 -27.48 27.77 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.24 -31.35 55.18 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.932 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.628 HD23 ' HE3' ' A' ' 19' ' ' LYS . 4.1 mt -77.09 -25.64 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 109.681 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.882 ' O ' HG22 ' A' ' 20' ' ' ILE . 18.1 mt -76.25 -22.1 55.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.791 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.89 -48.42 81.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.164 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.07 -11.57 35.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.174 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.882 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.1 tt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.282 -0.865 . . . . 0.0 111.69 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.3 t . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.781 0.324 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.693 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -62.19 -25.8 66.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.353 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -79.78 -45.26 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -8.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.255 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.693 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.95 -37.6 64.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.34 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.35 -26.34 30.85 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.26 -41.0 27.42 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.828 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -77.48 -20.05 54.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.358 0.599 . . . . 0.0 109.865 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.898 HD12 HG21 ' A' ' 20' ' ' ILE . 16.1 tp -76.86 -22.56 53.31 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.646 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.02 -50.09 73.42 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.372 -178.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.55 -11.32 34.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.898 HG21 HD12 ' A' ' 17' ' ' LEU . 7.3 tp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.754 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.543 HG12 ' CD1' ' A' ' 13' ' ' LEU . 46.4 t . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -62.46 -28.14 70.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -73.78 -49.16 26.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.5 -17.53 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.514 0.673 . . . . 0.0 110.164 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.543 ' CD1' HG12 ' A' ' 9' ' ' VAL . 9.1 mt -73.67 -28.23 61.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.852 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.3 -24.91 38.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.7 -38.9 41.78 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.033 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.831 HD13 ' HE3' ' A' ' 19' ' ' LYS . 4.2 mm? -77.4 -19.79 55.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.297 0.57 . . . . 0.0 110.006 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.1 tm? -75.77 -23.88 55.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.635 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.673 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.84 -50.27 72.93 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.68 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.831 ' HE3' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -92.34 -11.39 35.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.529 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.867 HG21 HD22 ' A' ' 17' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.785 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG12 ' HG ' ' A' ' 13' ' ' LEU . 51.6 t . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.953 0.406 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.57 -26.22 66.32 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.331 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.23 -48.52 28.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.037 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.94 -16.18 61.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.481 0.658 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 17' ' ' LEU . 9.8 mt -73.52 -28.66 62.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.959 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.23 -21.88 47.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.15 -38.33 35.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.29 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 5.3 mt -77.44 -23.32 50.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.33 0.586 . . . . 0.0 110.01 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.861 ' O ' HG22 ' A' ' 20' ' ' ILE . 41.1 mt -76.65 -22.4 54.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.46 -49.45 77.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.034 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.73 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.38 -10.14 39.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.358 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.861 HG22 ' O ' ' A' ' 17' ' ' LEU . 4.5 tt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.653 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.781 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -63.63 -27.0 70.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.308 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -74.41 -46.89 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.26 -9.26 58.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.144 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.781 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.83 -32.76 63.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.275 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . -83.21 -24.93 50.22 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.86 -47.22 77.09 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.49 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 9.0 mp -76.95 -16.53 59.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.64 0.733 . . . . 0.0 109.442 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.834 ' O ' HG22 ' A' ' 20' ' ' ILE . 6.6 tt -75.55 -22.76 56.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.729 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.659 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.4 -49.16 78.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.105 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.3 -10.26 39.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.38 . . . . 0.0 111.321 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.259 -0.876 . . . . 0.0 111.602 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -63.29 -27.76 71.2 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -81.3 -44.33 17.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.09 -16.64 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.601 HD12 ' HA2' ' A' ' 10' ' ' GLY . 8.6 mt -73.08 -29.03 62.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.72 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 17' ' ' LEU . . . -88.53 -26.76 26.7 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -77.05 -33.24 46.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.692 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.654 HD12 ' HE3' ' A' ' 19' ' ' LYS . 37.3 tp -77.91 -30.14 50.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.0 110.698 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -77.29 -22.06 52.59 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.148 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.15 -49.16 78.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -178.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.34 -11.99 33.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 111.306 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.668 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.66 HG12 ' CD1' ' A' ' 13' ' ' LEU . 41.8 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -58.04 -25.78 57.29 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -53.37 35.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.141 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 -24.38 58.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.556 0.693 . . . . 0.0 110.3 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.66 ' CD1' HG12 ' A' ' 9' ' ' VAL . 11.3 mt -73.97 -28.22 61.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.044 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.6 -21.82 61.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.96 45.02 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.113 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.486 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 20.2 mt -77.8 -19.25 55.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.405 0.621 . . . . 0.0 110.184 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.896 ' O ' HG22 ' A' ' 20' ' ' ILE . 6.7 tp -76.07 -22.58 55.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.61 -48.01 83.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.701 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.08 -11.19 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.883 0.373 . . . . 0.0 111.245 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.896 HG22 ' O ' ' A' ' 17' ' ' LEU . 4.1 tp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.481 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.66 -32.01 79.98 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -66.62 -51.47 55.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 109.899 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -70.78 -16.71 62.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.503 0.668 . . . . 0.0 110.149 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.56 HD12 ' HA2' ' A' ' 10' ' ' GLY . 8.4 mt -72.98 -28.31 62.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.97 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.3 -31.82 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.43 -36.17 45.16 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.633 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.503 HD23 ' HE3' ' A' ' 19' ' ' LYS . 15.6 mt -77.3 -15.11 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.618 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -74.54 -22.65 58.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.771 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.57 -47.68 80.54 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.303 -178.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.72 -13.74 28.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.279 179.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.718 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.519 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 77.5 t . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.94 0.4 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.59 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -63.33 -27.05 70.11 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.534 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -71.86 -47.84 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 -14.87 61.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.512 0.673 . . . . 0.0 110.069 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.59 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.7 mt -73.59 -28.83 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.989 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.61 -22.34 43.78 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.45 -41.95 50.19 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.801 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.46 -21.48 52.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.464 0.649 . . . . 0.0 109.757 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.938 HD12 HG21 ' A' ' 20' ' ' ILE . 14.2 tp -76.55 -22.59 54.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.882 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.87 -49.81 74.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.124 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.16 -10.18 39.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.389 . . . . 0.0 111.354 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.938 HG21 HD12 ' A' ' 17' ' ' LEU . 5.0 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.677 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.886 0.374 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tp -58.57 -33.31 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.489 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -148.78 99.06 0.19 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.76 -17.88 52.71 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.58 2.187 . . . . 0.0 112.573 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.533 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 18.0 t -63.47 -53.86 39.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.664 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.64 -27.77 65.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.264 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.41 -36.65 23.07 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.219 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 9' ' ' VAL . 2.0 pp -74.71 -44.57 49.3 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.06 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.7 t -62.34 -38.67 81.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.956 0.408 . . . . 0.0 109.949 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.96 -26.59 67.47 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.288 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -46.72 33.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.4 -17.98 62.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.586 0.707 . . . . 0.0 109.941 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.489 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.1 mt -73.58 -28.34 61.79 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.817 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.11 -26.48 28.53 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -74.92 -33.1 55.93 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 121.046 -0.597 . . . . 0.0 111.822 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.6 OUTLIER -77.46 -25.86 50.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.396 0.617 . . . . 0.0 109.588 178.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.85 ' O ' HG22 ' A' ' 20' ' ' ILE . 35.7 mt -77.3 -22.28 52.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.282 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.629 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.18 -50.06 75.49 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -178.297 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.725 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.58 -11.71 33.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.213 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.85 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.8 tp . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.226 -0.892 . . . . 0.0 111.732 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.3 pt . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.961 0.41 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.402 ' CD1' ' HD2' ' A' ' 4' ' ' PRO . 5.1 pt -90.57 -25.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.416 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.461 ' O ' HD23 ' A' ' 6' ' ' LEU . . . 145.9 -70.53 0.37 Allowed Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.633 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 18.3 Cg_exo -67.66 1.13 3.42 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.918 2.412 . . . . 0.0 113.357 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.28 -55.08 11.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.815 0.34 . . . . 0.0 111.062 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 3' ' ' GLY . 0.7 OUTLIER -50.51 -27.56 6.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.558 179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.9 -30.55 47.08 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 23.6 mt -75.74 -48.13 23.08 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.956 0.408 . . . . 0.0 109.941 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -56.64 -41.92 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.352 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.691 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.31 -28.35 69.14 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.115 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.9 t -81.11 -44.98 17.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.521 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -69.96 -16.62 63.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.54 0.686 . . . . 0.0 109.708 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.691 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.2 mt -67.57 -28.56 67.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.67 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.86 -26.3 32.26 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -73.94 -40.7 43.19 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.986 -0.626 . . . . 0.0 111.676 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 20' ' ' ILE . 3.4 mt -77.21 -15.85 59.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.33 0.586 . . . . 0.0 110.201 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.51 -24.05 50.1 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.062 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.689 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -55.24 -53.54 54.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.484 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.689 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -94.61 -24.65 17.11 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.734 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 17' ' ' LEU . 6.9 tp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.223 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 3' ' ' GLY . 2.8 mt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.849 0.357 . . . . 0.0 111.064 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.18 -20.89 28.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.397 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.482 ' H ' HG22 ' A' ' 1' ' ' ILE . . . 89.11 99.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.352 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.11 7.85 0.73 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.047 2.498 . . . . 0.0 113.539 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.0 t -52.93 -55.55 11.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.873 0.368 . . . . 0.0 111.137 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pp -51.67 -26.99 10.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.953 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.75 -27.07 65.69 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.609 -0.805 . . . . 0.0 111.216 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.06 -48.15 18.63 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.899 0.381 . . . . 0.0 110.342 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.417 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 47.7 t -59.7 -39.79 80.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.112 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.702 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -61.91 -28.96 71.13 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.302 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -44.41 27.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.16 -8.31 55.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.874 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.702 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.45 -29.03 62.28 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.126 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.485 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . -85.76 -29.83 25.42 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 110.748 -0.941 . . . . 0.0 110.748 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.445 ' O ' ' HE2' ' A' ' 18' ' ' LYS . . . -76.51 -32.48 50.94 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.302 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.53 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.3 tt -77.18 -19.69 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.271 0.557 . . . . 0.0 110.34 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.61 ' O ' HG22 ' A' ' 20' ' ' ILE . 26.0 mt -75.47 -22.14 57.51 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.65 -48.55 80.33 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.502 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.719 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.57 -12.31 34.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.997 0.427 . . . . 0.0 111.06 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.719 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.237 -0.887 . . . . 0.0 111.618 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 9.7 pt . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.826 0.346 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 2' ' ' ILE . 4.7 mt -86.28 58.63 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.084 0.469 . . . . 0.0 110.88 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -133.32 71.22 0.5 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.27 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.28 0.6 5.06 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.138 2.558 . . . . 0.0 113.267 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' HD21 ' A' ' 8' ' ' LEU . 16.6 t -53.32 -55.37 13.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.909 0.385 . . . . 0.0 111.151 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.85 -28.5 64.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.976 0.417 . . . . 0.0 110.459 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.92 -39.6 13.14 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.94 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 9' ' ' VAL . 2.5 pp -77.14 -48.37 17.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.116 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' N ' HD12 ' A' ' 8' ' ' LEU . 60.3 t -62.24 -34.82 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.96 0.41 . . . . 0.0 110.033 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.653 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -64.62 -29.69 75.88 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.27 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 t -77.24 -46.06 24.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -71.56 -18.31 62.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.046 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.653 HD12 ' HA2' ' A' ' 10' ' ' GLY . 6.5 mt -68.14 -31.85 71.71 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.804 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.4 -28.15 23.12 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.59 -34.12 45.35 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.439 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.526 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.16 -23.68 51.59 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.208 0.528 . . . . 0.0 110.052 179.482 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.716 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -77.16 -23.19 51.64 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.102 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.633 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.74 -50.82 69.55 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.449 -178.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.33 -9.64 41.19 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.319 -179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.718 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.717 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.577 HG22 ' H ' ' A' ' 3' ' ' GLY . 3.3 mp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.0 mt -68.98 -33.2 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.714 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.577 ' H ' HG22 ' A' ' 1' ' ' ILE . . . -128.22 85.51 0.32 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.131 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -63.58 -9.16 17.2 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.876 2.384 . . . . 0.0 113.322 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 16.2 t -56.54 -53.84 35.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 0.0 110.835 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mt -63.53 -27.44 69.26 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.12 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.47 -35.38 26.2 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.498 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 9' ' ' VAL . 4.1 pp -73.63 -43.96 58.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.817 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.657 ' N ' HD12 ' A' ' 8' ' ' LEU . 89.3 t -64.07 -40.22 88.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.652 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -62.31 -27.66 69.65 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.71 -45.63 20.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.67 -15.25 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.547 0.689 . . . . 0.0 109.82 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.652 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.2 mt -69.5 -27.99 65.66 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.159 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.15 -30.61 16.49 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.48 -0.866 . . . . 0.0 110.959 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.541 ' O ' ' CG ' ' A' ' 18' ' ' LYS . . . -76.5 -32.38 51.29 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.234 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -80.06 -18.84 48.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.354 0.597 . . . . 0.0 110.336 179.116 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.801 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -76.9 -23.75 52.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.015 -178.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.561 ' CE ' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.91 -46.75 89.43 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.011 -177.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.754 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.45 -14.13 31.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.114 0.483 . . . . 0.0 111.04 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.88 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.78 0.324 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.11 -39.92 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.332 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.5 85.76 0.3 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.358 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 27.4 Cg_exo -62.07 -13.76 33.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.729 2.286 . . . . 0.0 112.754 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.3 t -53.42 -55.33 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.116 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 pp -49.33 -27.49 3.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.879 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.04 -31.51 42.83 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.263 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 21.8 mt -77.19 -48.41 17.71 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.882 0.372 . . . . 0.0 110.383 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.11 -41.04 57.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.439 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -60.68 -25.86 64.08 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.51 -44.41 21.25 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.45 -15.05 62.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.51 0.671 . . . . 0.0 109.783 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.588 HD12 ' HA2' ' A' ' 10' ' ' GLY . 7.4 mt -69.12 -28.4 66.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.766 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.35 -21.89 57.71 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.92 -43.23 74.72 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.011 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 7.6 mp -77.14 -24.5 51.6 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.5 0.667 . . . . 0.0 109.623 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.893 HD12 HG21 ' A' ' 20' ' ' ILE . 11.6 tp -76.75 -22.58 53.6 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.707 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.66 -49.02 79.18 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.447 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.98 -11.39 36.2 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.0 0.428 . . . . 0.0 111.209 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.893 HG21 HD12 ' A' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.249 -0.881 . . . . 0.0 111.674 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.789 0.328 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.2 mp 65.29 95.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.141 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.86 -60.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.52 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.78 -12.12 30.06 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.787 2.325 . . . . 0.0 112.752 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.631 HG12 ' CG2' ' A' ' 9' ' ' VAL . 15.6 t -53.88 -55.13 15.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.179 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 mt -47.34 -27.78 1.75 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.044 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.36 -36.36 27.16 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.13 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -77.53 -46.78 21.31 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.631 ' CG2' HG12 ' A' ' 5' ' ' VAL . 23.4 t -54.94 -35.87 35.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.538 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.781 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.55 -29.19 71.14 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.581 -0.818 . . . . 0.0 111.361 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -81.79 -45.79 15.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.912 0.387 . . . . 0.0 110.095 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -70.63 -15.14 62.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.485 0.66 . . . . 0.0 109.822 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.781 HD12 ' HA2' ' A' ' 10' ' ' GLY . 6.2 mt -67.99 -28.48 67.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.819 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.22 -25.36 37.14 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.08 -43.56 21.17 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.768 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.699 HD23 ' NZ ' ' A' ' 19' ' ' LYS . 1.8 mt -77.04 -15.45 59.6 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 121.507 0.67 . . . . 0.0 109.987 178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.889 HD12 HG21 ' A' ' 20' ' ' ILE . 9.0 tp -75.26 -22.39 57.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.459 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.673 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.96 -48.95 79.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.145 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.63 -11.02 35.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.887 0.375 . . . . 0.0 111.359 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.889 HG21 HD12 ' A' ' 17' ' ' LEU . 1.2 tt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.739 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.884 0.373 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.5 pt -97.78 19.48 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.382 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.42 ' HA2' ' HD3' ' A' ' 4' ' ' PRO . . . 134.28 124.79 2.51 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.612 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' HA2' ' A' ' 3' ' ' GLY . 19.9 Cg_exo -67.24 -0.85 5.41 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.797 2.331 . . . . 0.0 113.291 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.701 ' HA ' HD23 ' A' ' 8' ' ' LEU . 61.5 t -53.28 -55.89 10.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.109 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.39 -28.32 69.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.461 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.66 -25.46 58.46 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.497 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.701 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -77.31 -43.14 34.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.547 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 43.7 t -69.26 -34.71 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -60.72 -26.18 64.59 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.2 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 m -69.79 -49.32 53.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.23 -21.47 63.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.66 0.743 . . . . 0.0 109.732 178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 17' ' ' LEU . 5.5 mt -73.64 -28.39 61.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.831 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.86 -22.85 48.08 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.28 -40.78 54.76 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.83 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD23 ' HZ2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.27 -22.21 52.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.35 0.595 . . . . 0.0 109.771 178.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.88 ' O ' HG22 ' A' ' 20' ' ' ILE . 21.6 mt -76.36 -22.51 54.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.668 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.2 -49.67 76.95 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.987 -178.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.738 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.71 -10.85 35.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.908 0.385 . . . . 0.0 111.387 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.5 tt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.268 -0.873 . . . . 0.0 111.679 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 2' ' ' ILE . 1.7 mt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.794 0.33 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.478 ' N ' HG22 ' A' ' 1' ' ' ILE . 1.0 OUTLIER -87.46 89.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.199 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . 173.99 -50.33 0.15 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.772 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 38.4 Cg_exo -60.19 -14.77 30.66 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.627 2.218 . . . . 0.0 112.881 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.754 ' HA ' HD23 ' A' ' 8' ' ' LEU . 21.5 t -55.6 -55.61 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.941 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -59.78 -28.57 67.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.575 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.0 -31.73 38.26 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.513 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.754 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -77.15 -44.23 31.07 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.661 0.267 . . . . 0.0 110.336 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.554 ' N ' ' HG ' ' A' ' 8' ' ' LEU . 51.8 t -70.07 -33.86 56.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.75 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -65.33 -27.99 73.07 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.3 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.57 -46.24 40.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.11 -9.77 58.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.068 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.75 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.82 -29.55 62.21 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.333 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.56 -22.8 49.45 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.14 -43.55 39.2 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.79 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.501 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -77.33 -23.46 50.94 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.43 0.633 . . . . 0.0 109.71 178.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.84 HD12 HG21 ' A' ' 20' ' ' ILE . 7.0 tp -76.78 -23.0 52.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.06 -49.24 78.66 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.367 -178.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -91.96 -11.49 36.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.875 0.369 . . . . 0.0 111.203 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.84 HG21 HD12 ' A' ' 17' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.51 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.605 ' N ' HD13 ' A' ' 1' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.481 ' N ' HG12 ' A' ' 1' ' ' ILE . 2.2 mp 65.75 73.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.137 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.37 91.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.33 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 33.4 Cg_exo -59.29 -19.25 49.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.585 2.19 . . . . 0.0 112.605 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -56.93 -55.3 20.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.084 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mt -49.26 -27.18 3.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.104 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.31 -28.09 56.44 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.63 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 11.8 mt -77.21 -48.45 17.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 120.927 0.394 . . . . 0.0 110.478 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -59.21 -41.58 84.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.226 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.646 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -61.87 -25.97 66.54 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.619 -0.801 . . . . 0.0 111.31 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -80.87 -44.6 18.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.08 -8.69 56.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.117 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.646 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.64 -31.66 63.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.27 179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.2 -30.7 16.07 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.53 -33.36 48.03 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 121.161 -0.542 . . . . 0.0 112.223 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.496 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -77.19 -20.39 55.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.291 0.567 . . . . 0.0 110.177 179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.876 ' O ' HG22 ' A' ' 20' ' ' ILE . 18.6 mt -76.55 -22.55 54.2 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.062 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.627 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.19 -49.3 78.19 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.023 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.722 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.68 -10.91 35.51 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.888 0.375 . . . . 0.0 111.262 179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.876 HG22 ' O ' ' A' ' 17' ' ' LEU . 2.0 tt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.669 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.79 0.328 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 pt -87.41 9.03 2.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.386 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.28 101.32 1.54 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.374 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -56.39 -21.29 36.46 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.519 2.146 . . . . 0.0 112.622 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.875 ' HA ' HD23 ' A' ' 8' ' ' LEU . 22.0 t -66.03 -55.41 19.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.751 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mt -60.19 -28.3 67.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.632 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.71 -29.46 47.85 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.55 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.875 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -77.14 -42.11 39.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.718 0.294 . . . . 0.0 110.551 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.619 HG12 ' CD1' ' A' ' 13' ' ' LEU . 46.2 t -67.98 -35.58 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.74 -27.19 69.58 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.178 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 60.7 m -75.05 -48.36 24.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.934 0.397 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.59 -16.92 60.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.431 0.634 . . . . 0.0 110.235 178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.745 ' O ' HD12 ' A' ' 17' ' ' LEU . 8.5 mt -74.03 -31.52 62.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.164 179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.38 -29.85 18.16 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.49 -33.79 46.86 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.089 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 4.8 tt -77.33 -20.9 54.21 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.31 0.576 . . . . 0.0 110.066 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.943 HD23 HG21 ' A' ' 20' ' ' ILE . 4.3 mt -76.73 -22.61 53.61 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.655 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.58 -48.43 81.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.116 -178.506 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.697 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.35 -11.01 36.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 111.22 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.943 HG21 HD23 ' A' ' 17' ' ' LEU . 9.2 tt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.293 -0.86 . . . . 0.0 111.616 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.922 0.391 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.2 pt -100.24 84.07 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.222 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.37 88.79 0.54 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.537 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.96 -18.17 55.79 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.563 2.175 . . . . 0.0 112.545 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.45 -55.38 21.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.701 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.2 mt -52.99 -26.96 16.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.734 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.81 -27.17 67.5 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.1 mt -75.94 -48.19 22.16 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.947 0.403 . . . . 0.0 109.995 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.03 -33.66 62.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.75 -28.45 70.04 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.7 m -70.11 -49.24 52.83 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-O 120.97 0.414 . . . . 0.0 110.007 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.3 -16.05 61.9 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.523 0.678 . . . . 0.0 110.154 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.635 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.0 mt -73.66 -33.92 64.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.823 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.29 -27.48 27.77 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.24 -31.35 55.18 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 121.174 -0.536 . . . . 0.0 111.932 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.628 HD23 ' HE3' ' A' ' 19' ' ' LYS . 4.1 mt -77.09 -25.64 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.392 0.615 . . . . 0.0 109.681 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.882 ' O ' HG22 ' A' ' 20' ' ' ILE . 18.1 mt -76.25 -22.1 55.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.791 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.89 -48.42 81.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.164 -178.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.07 -11.57 35.46 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.972 0.415 . . . . 0.0 111.174 179.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.882 HG22 ' O ' ' A' ' 17' ' ' LEU . 1.1 tt . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.282 -0.865 . . . . 0.0 111.69 -178.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.633 HG22 HG13 ' A' ' 2' ' ' ILE . 28.8 mt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.866 0.365 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.633 HG13 HG22 ' A' ' 1' ' ' ILE . 16.8 mt 68.92 -66.03 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.134 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.74 122.16 0.6 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.234 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.65 -13.55 26.58 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.484 2.123 . . . . 0.0 112.77 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' HA ' HD23 ' A' ' 8' ' ' LEU . 17.7 t -61.64 -56.04 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.923 0.392 . . . . 0.0 111.138 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.8 pp -57.52 -27.88 62.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.9 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.38 -35.84 25.3 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.298 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 5' ' ' VAL . 1.2 pp -77.47 -40.75 42.04 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.578 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 13' ' ' LEU . 88.3 t -64.46 -41.49 92.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.288 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.693 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -62.19 -25.8 66.9 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.353 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -79.78 -45.26 19.15 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.74 -8.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.255 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.693 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.95 -37.6 64.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.34 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.35 -26.34 30.85 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.414 -1.075 . . . . 0.0 110.414 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.26 -41.0 27.42 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 121.146 -0.549 . . . . 0.0 111.828 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.535 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.5 OUTLIER -77.48 -20.05 54.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.358 0.599 . . . . 0.0 109.865 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.898 HD12 HG21 ' A' ' 20' ' ' ILE . 16.1 tp -76.86 -22.56 53.31 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.868 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.646 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.02 -50.09 73.42 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.372 -178.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.55 -11.32 34.75 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.898 HG21 HD12 ' A' ' 17' ' ' LEU . 7.3 tp . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.754 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.888 0.375 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.8 pt -97.98 34.12 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.274 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.03 102.07 0.01 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.45 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -63.03 -14.87 44.23 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.64 2.227 . . . . 0.0 112.683 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -54.29 -55.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.004 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.99 -26.86 11.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.868 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.8 -25.93 61.59 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.559 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.9 mt -75.35 -48.32 23.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.835 0.35 . . . . 0.0 110.067 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.543 HG12 ' CD1' ' A' ' 13' ' ' LEU . 46.4 t -65.33 -35.06 74.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.401 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -62.46 -28.14 70.69 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -73.78 -49.16 26.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.871 0.367 . . . . 0.0 110.056 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.5 -17.53 61.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.514 0.673 . . . . 0.0 110.164 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.543 ' CD1' HG12 ' A' ' 9' ' ' VAL . 9.1 mt -73.67 -28.23 61.65 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.852 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.3 -24.91 38.36 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.7 -38.9 41.78 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.986 -0.625 . . . . 0.0 112.033 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.831 HD13 ' HE3' ' A' ' 19' ' ' LYS . 4.2 mm? -77.4 -19.79 55.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.297 0.57 . . . . 0.0 110.006 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.1 tm? -75.77 -23.88 55.98 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.635 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.673 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.84 -50.27 72.93 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.68 -178.357 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.831 ' HE3' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -92.34 -11.39 35.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.909 0.385 . . . . 0.0 111.529 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.867 HG21 HD22 ' A' ' 17' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.302 -0.856 . . . . 0.0 111.785 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 22.6 pt . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 2' ' ' ILE . 4.0 mp -142.62 51.6 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.078 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.23 -88.99 0.89 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.685 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.02 -16.07 43.19 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.579 2.186 . . . . 0.0 112.618 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.684 ' O ' HG23 ' A' ' 9' ' ' VAL . 28.3 t -58.66 -55.42 23.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.126 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.5 mt -58.18 -28.43 64.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.425 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.16 -40.53 11.32 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.01 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 9' ' ' VAL . 3.8 pp -77.48 -44.32 29.26 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.245 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 5' ' ' VAL . 51.6 t -58.9 -35.62 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.953 0.406 . . . . 0.0 110.307 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.57 -26.22 66.32 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.331 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.23 -48.52 28.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.906 0.384 . . . . 0.0 110.037 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.94 -16.18 61.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.481 0.658 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 17' ' ' LEU . 9.8 mt -73.52 -28.66 62.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.959 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.23 -21.88 47.13 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -76.15 -38.33 35.01 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.29 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 5.3 mt -77.44 -23.32 50.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.33 0.586 . . . . 0.0 110.01 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.861 ' O ' HG22 ' A' ' 20' ' ' ILE . 41.1 mt -76.65 -22.4 54.12 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.921 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.46 -49.45 77.74 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.034 -178.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.73 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.38 -10.14 39.19 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.91 0.386 . . . . 0.0 111.358 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.861 HG22 ' O ' ' A' ' 17' ' ' LEU . 4.5 tt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.263 -0.875 . . . . 0.0 111.653 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.647 ' N ' HD13 ' A' ' 1' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.818 0.342 . . . . 0.0 111.126 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.863 HG22 HG23 ' A' ' 5' ' ' VAL . 12.8 mm -71.69 90.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.504 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . -76.67 -41.41 24.28 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.371 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.504 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 79.7 Cg_exo -45.37 -26.85 2.82 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.459 2.106 . . . . 0.0 113.139 -179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.863 HG23 HG22 ' A' ' 2' ' ' ILE . 29.5 t -59.09 -55.54 22.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.986 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pp -49.99 -26.98 4.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.021 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.78 -27.76 58.17 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.653 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.5 mt -77.12 -48.51 17.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.868 0.366 . . . . 0.0 110.355 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.2 t -62.43 -35.18 68.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.833 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.781 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . -63.63 -27.0 70.32 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.308 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -74.41 -46.89 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.26 -9.26 58.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.144 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.781 HD23 ' HA2' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -73.83 -32.76 63.85 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.275 179.611 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . -83.21 -24.93 50.22 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 178.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.86 -47.22 77.09 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.49 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 9.0 mp -76.95 -16.53 59.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.64 0.733 . . . . 0.0 109.442 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.834 ' O ' HG22 ' A' ' 20' ' ' ILE . 6.6 tt -75.55 -22.76 56.75 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.729 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.659 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.4 -49.16 78.0 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.105 -178.652 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.3 -10.26 39.01 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.899 0.38 . . . . 0.0 111.321 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.259 -0.876 . . . . 0.0 111.602 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 2' ' ' ILE . 10.4 tp . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.793 0.33 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.406 ' N ' HG13 ' A' ' 1' ' ' ILE . 0.7 OUTLIER -47.89 -27.76 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.459 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.21 81.41 0.34 Allowed Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.259 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 31.4 Cg_exo -58.83 -24.39 71.78 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.609 2.206 . . . . 0.0 112.702 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.8 -55.58 23.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.737 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 mt -52.73 -26.7 14.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.808 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.07 -26.59 61.78 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.662 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 19.3 mt -74.9 -48.0 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.906 0.384 . . . . 0.0 110.035 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.09 -41.77 94.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.863 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.601 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -63.29 -27.76 71.2 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 m -81.3 -44.33 17.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.09 -16.64 62.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.831 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.601 HD12 ' HA2' ' A' ' 10' ' ' GLY . 8.6 mt -73.08 -29.03 62.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.72 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.44 ' HA2' ' CD2' ' A' ' 17' ' ' LEU . . . -88.53 -26.76 26.7 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.437 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -77.05 -33.24 46.05 Favored Glycine 0 N--CA 1.442 -0.965 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.692 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.654 HD12 ' HE3' ' A' ' 19' ' ' LYS . 37.3 tp -77.91 -30.14 50.46 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.246 0.546 . . . . 0.0 110.698 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -77.29 -22.06 52.59 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.148 -179.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.15 -49.16 78.92 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.258 -178.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.709 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.34 -11.99 33.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.96 0.41 . . . . 0.0 111.306 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.289 -0.862 . . . . 0.0 111.668 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.5 mt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.855 0.36 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.705 ' CG2' HG21 ' A' ' 5' ' ' VAL . 1.6 mp -93.02 45.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.012 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' N ' ' CD ' ' A' ' 4' ' ' PRO . . . -93.41 -49.88 2.49 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.853 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' CD ' ' N ' ' A' ' 3' ' ' GLY . 45.5 Cg_exo -56.28 -19.42 27.89 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.558 2.172 . . . . 0.0 112.782 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.705 HG21 ' CG2' ' A' ' 2' ' ' ILE . 18.2 t -54.72 -55.46 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.986 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -26.78 6.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.877 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.58 -26.73 60.48 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.543 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.06 -48.57 17.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.776 0.322 . . . . 0.0 110.158 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.66 HG12 ' CD1' ' A' ' 13' ' ' LEU . 41.8 t -62.23 -35.22 67.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 13' ' ' LEU . . . -58.04 -25.78 57.29 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.6 -53.37 35.04 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.97 0.414 . . . . 0.0 110.141 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.91 -24.38 58.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.556 0.693 . . . . 0.0 110.3 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.66 ' CD1' HG12 ' A' ' 9' ' ' VAL . 11.3 mt -73.97 -28.22 61.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.044 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -81.6 -21.82 61.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.9 -48.96 45.02 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.113 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.486 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 20.2 mt -77.8 -19.25 55.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.405 0.621 . . . . 0.0 110.184 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.896 ' O ' HG22 ' A' ' 20' ' ' ILE . 6.7 tp -76.07 -22.58 55.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.766 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.634 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.61 -48.01 83.34 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.129 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.701 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.08 -11.19 36.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.883 0.373 . . . . 0.0 111.245 179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.896 HG22 ' O ' ' A' ' 17' ' ' LEU . 4.1 tp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.481 -178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.786 HG22 HG13 ' A' ' 2' ' ' ILE . 4.1 mt . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 120.804 0.335 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.786 HG13 HG22 ' A' ' 1' ' ' ILE . 14.4 mt -136.06 40.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.0 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' A' ' 6' ' ' LEU . . . 156.78 125.85 0.9 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.018 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.49 -23.52 39.64 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.471 2.114 . . . . 0.0 112.943 -179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -53.43 -55.76 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.328 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 6' ' ' LEU . 3.7 pp -55.47 -26.7 43.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.718 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.67 -31.17 60.85 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.02 -48.54 17.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.9 -31.86 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.599 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -61.66 -32.01 79.98 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -66.62 -51.47 55.88 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.961 0.41 . . . . 0.0 109.899 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' O ' HD12 ' A' ' 16' ' ' LEU . . . -70.78 -16.71 62.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.503 0.668 . . . . 0.0 110.149 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.56 HD12 ' HA2' ' A' ' 10' ' ' GLY . 8.4 mt -72.98 -28.31 62.31 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.97 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.3 -31.82 13.24 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.43 -36.17 45.16 Favored Glycine 0 N--CA 1.442 -0.962 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.633 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.503 HD23 ' HE3' ' A' ' 19' ' ' LYS . 15.6 mt -77.3 -15.11 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.286 0.565 . . . . 0.0 109.988 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.618 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -74.54 -22.65 58.91 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.771 -179.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.608 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.57 -47.68 80.54 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.303 -178.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.718 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.72 -13.74 28.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.794 0.331 . . . . 0.0 111.279 179.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.718 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.208 -0.901 . . . . 0.0 111.519 -178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.2 mm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.753 0.311 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 2' ' ' ILE . 1.1 tp 43.32 54.27 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.742 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.42 ' N ' ' HD3' ' A' ' 4' ' ' PRO . . . -166.24 63.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.522 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.42 ' HD3' ' N ' ' A' ' 3' ' ' GLY . 22.2 Cg_exo -65.96 -12.23 34.44 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.755 2.303 . . . . 0.0 112.814 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HA ' ' CG ' ' A' ' 8' ' ' LEU . 17.5 t -54.16 -55.39 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 mt -57.83 -28.14 63.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.422 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.61 -38.88 15.64 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.852 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.55 HD12 ' N ' ' A' ' 9' ' ' VAL . 1.5 pp -77.08 -48.0 19.01 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.209 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' N ' HD12 ' A' ' 8' ' ' LEU . 77.5 t -58.97 -31.91 46.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.94 0.4 . . . . 0.0 110.16 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.59 ' HA2' HD12 ' A' ' 13' ' ' LEU . . . -63.33 -27.05 70.11 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.534 179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 m -71.86 -47.84 50.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.907 0.384 . . . . 0.0 110.107 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.19 -14.87 61.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.512 0.673 . . . . 0.0 110.069 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.59 HD12 ' HA2' ' A' ' 10' ' ' GLY . 9.7 mt -73.59 -28.83 62.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.989 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.61 -22.34 43.78 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' O ' ' CE ' ' A' ' 18' ' ' LYS . . . -72.45 -41.95 50.19 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.801 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -77.46 -21.48 52.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 121.464 0.649 . . . . 0.0 109.757 178.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.938 HD12 HG21 ' A' ' 20' ' ' ILE . 14.2 tp -76.55 -22.59 54.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.882 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.644 ' HG2' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.87 -49.81 74.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.124 -178.497 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HD2' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.16 -10.18 39.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.389 . . . . 0.0 111.354 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.938 HG21 HD12 ' A' ' 17' ' ' LEU . 5.0 tt . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.677 -178.762 . . . . . . . . 1 1 . 1 stop_ save_